Publications

Editorials and opinion pieces in national media

1. Nyunt MM and Plowe C. Malaria as a Catalyst for Change in Myanmar [Commentary]. Roll Call, August 18, 2015.

2. Nyunt MM and Plowe C. Pursuing Disease Diplomacy in Myanmar [Op-Ed]. The Los Angeles Times, December 14, 2015.

3. Plowe CV. Taking the Battle Against Malaria to the Mekong [Op-Ed]. The New York Times, September 26, 2017.

4. Plowe CV. Malaria kills 1,000 children daily, now there’s a vaccine to fight it [Opinion]. The Hill, April 24, 2019.

Editorials, position, and background papers:

1. Laufer MK, Plowe CV. Cotrimoxazole prophylaxis and malaria in Africa: Have the important questions been answered? American Journal of Tropical Medicine & Hygiene 75:373-374, 2006.

2. Plowe CV. Combination therapy for malaria: Mission accomplished? Clinical Infectious Diseases 44:1075-1077, 2007.

3. Breman JG, Plowe CV. A malaria vaccine for control: more progress. Journal of Infectious Diseases 200:317-320, 2009.

4. Plowe CV, Alonso P, Hoffman SL. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. Journal of Infectious Diseases 200:1646-1649, 2009.

5. Dondorp AM, Fairhurst RM, Slutsker L, MacArthur JR, Breman JG, Guerin PJ, Wellems TE, Ringwald P, Newman RD, Plowe CV. Perspective: The threat of Artemisinin-resistant malaria. New England Journal of Medicine 365:1075-1077, 2011.

6. Plowe CV. Resistance nailed. Nature News & Views 505:30-31, 2014.

7. Plowe CV. Vaccine-resistant malaria. New England Journal of Medicine 373:2082-2083, 2015.

8. Plowe CV. Presidential Address: Tropical medicine in war and peace. American Journal of Tropical Medicine & Hygiene 95:5-9, 2016.

9. Plowe CV. In Memoriam: A Tribute to Alan Magill. Trends in Parasitology 32:265-266, 2016.

10. Rosenthal PJ, Hill DR, Bausch DG, Goraleski KA, Higgs S, Walker PF, Plowe CV. The (International) American Society of Tropical Medicine & Hygiene. American Journal of Tropical Medicine & Hygiene 95:980-982, 2017.

11. Rosenthal PJ, Bausch DG, Higgs S, Rabinovich NR, Hill DR, Plowe CV, Goraleski KA, Walker PF. Evidence-based policies on migration and global health are essential to maintain the health of those inside and outside the United States. American Journal of Tropical Medicine & Hygiene 96:5-6, 2017.

12. Djimdé A, Miller LH, Plowe CV. Professor Ogobara K. Doumbo (1956-June 9, 2018). American Journal of Tropical Medicine & Hygiene 99:1118-1119, 2018.

Book Reviews:

1. Plowe CV. Review of The Fever: how malaria has ruled humankind for 500,000 years. The Journal of Clinical Investigation 120:4167, 2010.

2. Plowe CV. Review of Vaccine Design: Innovative Approaches and Novel Strategies. Clinical Infectious Diseases 53:318, 2011.

Reports:

1. Plowe CV. The Danger of Untreatable Malaria is Real and Present. A Report of the Center for Strategic and International Studies (CSIS) Global Health Policy Center, December 2014.

Chapters in books:

1. Plowe CV. Malaria. Red Book: Report of the Committee on Infectious Diseases, 24th Ed., American Academy of Pediatrics. Peter G (ed.) 1997.

2. Plowe CV. Folate antagonists and mechanisms of resistance. Antimalarial Chemotherapy, Infectious Diseases Series, Humana Press. Rosenthal P (ed.) 2001.

3. Cao K, Lyke KE, Masaberg C, Doumbo O, Ng J, Hartzman R, Plowe CV, Sztein M, Fernández-Viña M. Distribution and association of alleles at the HLA class I-A, B and C loci in a Malian population. HLA 2002. Immunobiology of the Human MHC. Hansen, J and Dupont, B, (eds.) 2003.

4. Nyunt M, Plowe CV. Malaria. Pharmacology and therapeutics: principles to practice. Saunders. Waldman SA, Terzic A (eds.) 2009.

5. Berry A, Nyunt M, Plowe CV. Malaria: Clinical and epidemiological aspects. Immunology of Infectious Diseases. ASM Press. Kaufmann S, Rouse B, Sacks D (eds.), 2010.

6. Tapia MD, Kotloff KL, Plowe CV, Sow SO. Special issues in performing vaccine trials in developing countries. New Generation Vaccines. Informa Healthcare. Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R (eds.) 2010.

7. Weijer C, Lanata CF, Plowe CV. Ethical considerations in the conduct of vaccine trials in developing countries. New Generation Vaccines. Informa Healthcare. Levine MM, Dougan G, Good MF, Liu MA, Nabel GJ, Nataro JP, Rappuoli R (eds.) 2010.

8. Jacob C, Plowe CV. Malaria genomics and the developing world. Genomics Applications for the Developing World. Nelson KE, Jones-Nelson, B (eds.) 2012.

9. Plowe CV. Malaria vaccines. Infectious Diseases, A Volume in the Encyclopedia of Sustainability Science and Technology. Springer. Kanki P, Meyers R (eds.) 2013.

10. Laurens MB, Plowe CV. Malaria vaccines. Encyclopedia of Sustainability Science and Technology (2nd Edition). Springer. Shulman LM (ed.) 2023.

Published scientific reviews (for mass distribution)

1. Plowe CV, Wellems T. Molecular approaches to the spreading problem of drug resistant malaria. Advances in Experimental Medicine and Biology 390:197-209, 1995.

2. Plowe CV, Kublin JG, Doumbo OK. P. falciparum DHFR and DHPS mutations: Epidemiology and role in clinical resistance to antifolates. Drug Resistance Updates 1:389-396, 1998.

3. Carlton JM, Fidock DA, Djimde A, Plowe CV, Wellems T. Conservation of a novel vacuolar transporter in Plasmodium species and its central role in chloroquine resistance of P. falciparum. Current Opinions in Microbiology 4:415-420, 2001.

4. Wellems TE, Plowe CV. Chloroquine-resistant malaria. Journal of Infectious Diseases 184:770-776, 2001.

5. Sibley C, Hyde J, Sims P, Plowe C, Kublin J, Mberu E, Cowman A, Winstanley P, Watkins W, Nzila A. Pyrimethamine/sulfadoxine resistance in Plasmodium falciparum: What next? Trends in Parasitology 17:582-588, 2001.

6. Plowe CV. Monitoring antimalarial drug resistance: making the most of the tools at hand. Journal of Experimental Biology 206:3745-3752, 2003.

7. Laufer MK, Plowe CV. Withdrawing antimalarial drugs: Impact on parasite resistance and implications for malaria treatment policies. Drug Resistance Updates 7:279-288, 2004.

8. Gregson A, Plowe CV. Mechanisms of resistance of malaria parasites to antifolates. Pharmacological Reviews 57:117-145, 2005.

9. Heppner DG, Kester KE, Ockenhouse CF, Tornieporth N, Ofori O, Lyon JA, Stewart VA, Dubois P, Lanar DE, Krzych U, Moris P, Angov E, Cummings J, Leach A, Hall B, Dutta S, Schwenk R, Hillier C, Barbosa A, Ware L, Nair L, Darko CA, Withers MR, Ogutu B, Polhemus ME, Fukuda M, Pichyangkul S, Gettyacamin M, Diggs C, Soisson L, Milman J, Dubois M, Garcon N, Tucker K, Wittes J, Plowe CV, Thera M, Doumbo OK, Pau MG, Goudsmit J, Ballou WR, Cohen J. Towards an RTS,S-based, multi-stage, multi-antigen vaccine against falciparum malaria: progress at the Walter Reed Army Institute of Research. Vaccine 23:2243-2250, 2005.

10. Plowe CV. Antimalarial drug resistance in Africa: Strategies for monitoring and deterrence. Current Topics in Microbiology and Immunology 295:55-79, 2005.

11. Laufer MK, Plowe CV. The interaction between HIV and malaria in Africa. Current Infectious Disease Reports 9:47-54, 2007.

12. Nyunt MM, Plowe CV. Pharmacologic advances in the global control and treatment of malaria: combination therapy and resistance. Clinical Pharmacology and Therapeutics 82:601-605, 2007.

13. Sibley CH, Barnes KI, Plowe CV. The rationale and plan for creating a World Antimalarial Resistance Network (WARN). Malaria Journal 6:118, 2007.

14. Barnes KI, Lindegardh N, Ogundahunsi O, Olliaro P, Plowe CV, Randrianarivelojosia M, Gbotosho GO, Watkins WM, Sibley CH, White NJ. World Antimalarial Resistance Network (WARN) IV: clinical pharmacology. Malaria Journal 6:122, 2007.

15. Plowe CV, Roper C, Barnwell JW, Happi CT, Joshi HH, Mbacham W, Meshnick SR, Mugittu K, Naidoo I, Price RN, Shafer RW, Sibley CH, Sutherland CJ, Zimmerman PA, Rosenthal PJ. World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria. Malaria Journal 6:121, 2007.

16. Price RN, Dorsey G, Ashley EA, Barnes KI, Baird JK, d'Alessandro U, Guerin PJ, Laufer MK, Naidoo I, Nosten F, Olliaro P, Plowe CV, Ringwald P, Sibley CH, Stepniewska K, White NJ. World Antimalarial Resistance Network I: clinical efficacy of antimalarial drugs. Malaria Journal 6:119, 2007.

17. Laufer ML, Djimde AA, Plowe CV. Monitoring and deterring drug resistant malaria in the era of combination therapy. American Journal of Tropical Medicine & Hygiene 77:160-169, 2007.

18. Sibley CH, Barnes KI, Watkins WM, Plowe CV. A network to monitor antimalarial drug resistance: a plan for moving forward. Trends in Parasitology 24:43-48, 2008.

19. Plowe CV. The evolution of drug-resistant malaria. Transactions of the Royal Society of Tropical Medicine & Hygiene, 103:S11-14, 2009.

20. Takala SL, Plowe CV. Genetic diversity and malaria vaccine design, testing and efficacy: preventing and overcoming 'vaccine resistant malaria'. Parasite Immunology 31:560-573, 2009.

21. Plowe CV, Alonso P, Hoffman SL. The potential role of vaccines in the elimination of falciparum malaria and the eventual eradication of malaria. Journal of Infectious Diseases 200:1646-1649, 2009.

22. Hoffman SL, Billingsley PF, James E, Richman A, Loyevsky M, Li T, Chakravarty S, Gunasekera A, Li M, Stafford R, Ahumada A, Epstein JE, Sedegah M, Reyes S, Richie TL, Lyke KE, Edelman R, Laurens M, Plowe CV, Sim BK. Development of a metabolically active, non-replicating sporozoite vaccine to prevent Plasmodium falciparum malaria. Human Vaccines 6:97-106, 2010.

23. Alonso PL, Brown G, Arevalo-Herrera M, Binka F, Chitnis C, Collins F, Doumbo OK, Greenwood B, Hall BF, Levine MM, Mendis K, Newman N, Plowe CV, Rodríguez MH, Sinden R, Slutsker L, Tanner M. A research agenda to underpin malaria eradication. PLoS Medicine 8:e1000406, 2011.

24. The malERA Consultative Group on Drugs (corresponding author). A Research Agenda for Malaria Eradication: Drugs. PLoS Medicine 8:e1000402, 2011.

25. The malERA Consultative Group on Vaccines. A Research Agenda for Malaria Eradication: Vaccines. PLoS Medicine 8:e1000398, 2011.

26. Thera MA, Plowe CV. Vaccines for malaria: how close are we? Annual Review of Medicine 63:345-357, 2012.

27. Fairhurst RM, Nayyar GM, Breman JG, Hallett R, Vennerstrom JL, Duong S, Ringwald P, Wellems TE, Plowe CV, Dondorp AM. Artemisinin-resistant malaria: research challenges, opportunities, and public health implications. American Journal of Tropical Medicine & Hygiene 87:231-241, 2012.

28. Venkatesan M, Alifrangis M, Roper C, Plowe CV. Monitoring antifolate resistance in intermittent preventive therapy for malaria. Trends in Parasitology 29:497-504, 2013.

29. Plowe CV. The Jeremiah Metzger lecture: new additions to the toolbox for global malaria eradication. Transactions of the American Clinical and Climatological Association 125:271-280, 2014.

30. Ouattara A, Barry AE, Dutta S, Remarque EJ, Beeson JG, Plowe CV. Designing malaria vaccines to circumvent antigen variability. Vaccine 33:7506-7512, 2015.

31. Plowe CV. Malaria chemoprevention and drug resistance: a review of the literature and policy implications. Malaria Journal. 2022 21:104. 2022.

Refereed journal articles

1. Friedman R, Shear M, von Bulow B, Sweeney J, Plowe C. Compliance and outcome of patients accompanied by relatives to evaluations. Hospital & Community Psychiatry 35(10):1037-1038, 1984.

2. Hoffman S, Moechtar M, Simanjuntak C, Punjabi N, Kumala S, Silasahi P, Sutopo B, Kuncoro Y, Soriano M, Plowe C, Paleologo F, Edman D, Laughlin L. Rehydration and maintenance therapy of cholera patients in Jakarta: Citrate based versus bicarbonate based oral rehydration salt solution. Journal of Infectious Diseases 152:1159 1165, 1985.

3. von Bulow B, Sweeney J, Shear M, Friedman R, Plowe C. Family satisfaction with psychiatric evaluations. Health & Social Work 12:290 295, 1987.

4. Hoffman S, Oster C, Plowe CV, Woollett G, Beier J, Chulay J, Wirtz R, Hollingdale M, Mugambi M. Naturally acquired antibodies to sporozoites do not prevent malaria: Vaccine development implications. Science 237:639 642, 1987.

5. Vaidya A, Morrisey J, Plowe CV, Kaslow D, Wellems T. Unidirectional dominance of cytoplasmic inheritance in two genetic crosses of Plasmodium falciparum. Molecular and Cellular Biology 13:7349-7357, 1993.

6. Plowe CV, Djimde A, Bouare M, Doumbo OK, Wellems TE. Pyrimethamine and proguanil resistance-conferring mutations in Plasmodium falciparum dihydrofolate reductase: Polymerase chain reaction methods for surveillance in Africa. American Journal of Tropical Medicine & Hygiene 52:565-568, 1995.

7. Plowe CV, Djimde A, Wellems T, Kouriba B, Diop S, Doumbo OK. Community pyrimethamine use and prevalence of resistant Plasmodium falciparum genotypes in Mali: A model for deterring resistance. American Journal of Tropical Medicine & Hygiene 55:467-471, 1996.

8. Plowe CV, Cortese J, Djimde A, Nwanyanwu O, Watkins W, Winstanley P, Estrada-Franco J, Mollinedo R, Avila J, Cespedes J, Carter D, Doumbo OK. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance. Journal of Infectious Diseases 176:1590-1596, 1997.

9. Watkins W, Mberu E, Winstanley P. The efficacy of antifolate antimalarial combinations in Africa: a predictive model Plowe CV based on pharmacodynamic and pharmacokinetic analyses. Parasitology Today 13:459-464, 1997.

10. Nzila-Mounda A, Mberu E, Sibley C, Plowe CV, Winstanley P, Watkins W. Kenyan Plasmodium falciparum field isolates: correlation between pyrimethamine and chlorcycloguanil activity in vitro and point mutations in dihydrofolate reductase. Antimicrobial Agents and Chemotherapy 42:164-169, 1998

11. Kublin J, Witzig R, Shankar A, Quintana Zurita J, Gilman R, Aramburu Guarda J, Cortese J, Plowe CV. Molecular assays for surveillance of antifolate-resistant malaria. Lancet 351:1629-1630, 1998.

12. Perry R, Plowe CV, Koumare B, Bougoudogo F, Kotloff K, Losonsky G, Wasserman S, Levine M. A single dose of live oral cholera vaccine CVD 103-HgR is safe and immunogenic in HIV-infected and non-infected adults in Mali. Bulletins of the World Health Organization 76:63-71, 1998.

13. Djimde A, Plowe CV, Diop S, Dicko A, Wellems TE, Doumbo OK. Use of antimalarial drugs in Mali: Policy v. Reality. American Journal of Tropical Medicine & Hygiene 59:376-379, 1998.

14. Cortese J, Plowe CV. Antifolate resistance due to new and known Plasmodium falciparum dihydrofolate reductase mutations expressed in yeast. Molecular and Biochemical Parasitology 94:205-214, 1998.

15. Diourte Y, Djimde A, Doumbo OK, Sagara I, Coulibaly Y, Dicko A, Diallo M, Diakite M, Cortese J, Plowe CV. Pyrimethamine-sulfadoxine efficacy and selection for mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase in Mali. American Journal of Tropical Medicine & Hygiene 60:475-478, 1999.

16. Watkins W, Mberu E, Winstanley P, Plowe CV. More on the efficacy of antifolate antimalarial combinations in Africa (Comment). Parasitology Today 15:131-132, 1999.

17. Urdaneta L, Plowe C, Goldman I, Lal A. Point mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum isolates from Venezuela. American Journal of Tropical Medicine & Hygiene 61:457-462, 1999.

18. Doumbo OK, Kayentao K, Djimde A, Cortese J, Diourte Y, Konare A, Kublin J, Plowe CV. Rapid selection of P. falciparum DHFR mutants in vivo by pyrimethamine prophylaxis. Journal of Infectious Diseases 182:993-996, 2000.

19. Agarwal A, Guindo A, Cissoko Y, Taylor J, Coulibaly D, Kone A, Kayentao K, Djimde A, Plowe CV, Doumbo OK, Wellems TE, Diallo D. Hemoglobin C associated with protection from severe malaria in the Dogon country of Mali, a West African population with a low prevalence of Hemoglobin S. Blood 96:2358-2363, 2000.

20. Vasconcelos K, Plowe CV, Fontes C, Kyle D, Wirth D, Pereira da Silva L, Zalis M. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase of isolates from the Amazon region of Brazil. Memorias do Instituto Oswaldo Cruz 95:721-728, 2000.

21. Djimdé A, Doumbo OK, Cortese J, Kayentao K, Doumbo S, Diourté Y, Coulibaly D, Dicko A, Su X, Fidock D, Nomura T, Wellems TE, Plowe CV. A molecular marker for chloroquine resistant falciparum malaria. New England Journal of Medicine 344:257-263, 2001.

22. Salcedo E, Cortese J, Plowe CV, Sims P, Hyde J. A bifunctional dihydrofolate synthetase-folylpolyglutamate synthetase in Plasmodium falciparum identified by functional complementation in yeast and bacteria. Molecular and Biochemical Parasitology 112:239-252, 2001.

23. Plowe CV, Doumbo OK, Djimde A, Kayentao K, Diourte Y, Doumbo S, Coulibaly D, Thera M, Wellems TE, Diallo D. Chloroquine treatment of uncomplicated Plasmodium falciparum malaria in Mali: Parasitological resistance vs. therapeutic efficacy. American Journal of Tropical Medicine & Hygiene 64:242-246, 2001.

24. Djimde A, Doumbo OK, Steketee R, Plowe CV. Application of a molecular marker for surveillance of chloroquine-resistant falciparum malaria. Lancet 358:890-891, 2001.

25. Iyer J, Milhous W, Cortese J, Kublin J, Plowe CV. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358:1066-1067, 2001.

26. Kublin J, Dzinjalamala FK, Kamwendo D, Malkin E, Cortese J, Martino L, Mukadam R, Rogerson S, Lescano A, Molyneux M, Winstanley P, Chimpeni P, Taylor TE, Plowe CV. Molecular markers for treatment failure of sulfadoxine-pyrimethamine and chlorproguanil-dapsone for falciparum malaria and a model for practical application in Africa. Journal of Infectious Diseases 185:380-388, 2002.

27. Mendez F, Munoz A, Carrasquilla G, Jurado D, Arevalo-Herrera M, Cortese J, Plowe CV. Determinants of treatment response to sulfadoxine- pyrimethamine and subsequent transmission potential in falciparum malaria. American Journal of Epidemiology 156:230-238, 2002.

28. Cortese J, Caraballo A, Contreras C, Plowe CV. Origin and dissemination of Plasmodium falciparum drug-resistance mutations in South America. Journal of Infectious Diseases 186:999-1006, 2002.

29. Sulo J, Chimpeni P, Hatcher J, Kublin J, Plowe CV, Molyneux M, Marsh K, Taylor T, Watkins W, Winstanley P. Randomised clinical trial of chlorproguanil-dapsone (LAPDAP) versus sulfadoxine-pyrimethamine for sequential episodes of uncomplicated falciparum malaria in Kenya and Malawi. Lancet 360:1136-1143, 2002.

30. Contreras C, Cortese J, Caraballo A, Plowe CV. Genetics of drug-resistant falciparum malaria in the Venezuelan state of Bolivar. American Journal of Tropical Medicine & Hygiene 186:999-1006, 2002.

31. El Setouhy M, Agbenyega T, Anto F, Clerk C, Koram K, English M, Molyneux C, Peshu N, Juma R, Kumwenda N, Mfutso-Bengu J, Molyneux M, Taylor T, Diarra D, Maiga S, Sylla M, Youssouf D, Falade C, Gbadegesin S, Lie R, Mugusi F, Ngassapa D, Ecuru J, Talisuna A, Emanuel E, Grady C, Wendler D, Higgs E, Plowe C, Sugarman J. Fair benefits for research in developing countries. Science 298:2133-2134, 2002.

32. Rowe J, Diallo D, Baby M, Poudiougo B, Coulibaly D, Cockburn I, Middleton J, Lyke K, Plowe CV, Doumbo OK, Moulds J. Erythrocyte complement receptor one expression level does not correlate with a Hind III restriction fragment length polymorphism in Africans; implications for studies on malaria susceptibility. Genes and Immunity 3:497-500, 2002.

33. Coulibaly D, Diallo D, Thera M, Dicko A, Guindo A, Koné A, Cissoko Y, Coulibaly S, Djimdé A, Lyke K, Doumbo OK, Plowe CV. Impact of pre-season treatment on incidence of falciparum malaria and parasite density at a site for testing malaria vaccines in Bandiagara, Mali. American Journal of Tropical Medicine & Hygiene 67:604-610, 2002.

34. Kublin J, Cortese J, Njunju E, Mukadam R, Wirima J, Kazembe P, Djimdé A, Kouriba B, Taylor T, Plowe CV. Reemergence of chloroquine-sensitive Plasmodium falciparum malaria following cessation of chloroquine use in Malawi. Journal of Infectious Diseases 187:1870-1875, 2003.

35. Lyke KE, Diallo D, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Sangare L, Coulibaly S, Dakouo B, Taylor TE, Doumbo OK, Plowe CV. Association of intraleukocytic Plasmodium falciparum malaria pigment with disease severity, clinical manifestations and prognosis in severe malaria. American Journal of Tropical Medicine & Hygiene 69:253-259, 2003.

36. Djimdé A, Doumbo OK, Traore O, Guindo A, Kayentao K, Diourté Y, Niare-Doumbo S, Coulibaly D, Koné A, Cissoko Y, Tekete M, Fofana B, Dicko A, Diallo D, Wellems TE, Kwiatkowski D, Plowe CV. Clearance of drug-resistant parasites as a model for protective immunity in falciparum malaria. American Journal of Tropical Medicine & Hygiene 69:558-563, 2003.

37. Moulds J, Thomas B, Doumbo OK, Diallo D, Lyke KE, Plowe CV, Rowe J, Birmingham D. Identification of the Kna/Knb polymorphism and a method for Knops genotyping. Transfusion 44:164-169, 2004. PMCID: PMC2877259.

38. Plowe CV, Kublin J, Dzinjalamala FK, Kamwendo D, Mukadam R, Chimpeni P, Molyneux M, Taylor TE. Sustained sulfadoxine-pyrimethamine efficacy for uncomplicated falciparum malaria in Malawi after ten years as first line therapy. British Medical Journal 328:545-548, 2004.

39. Cao K, Moormann A, Lyke KE, Masaberg C, Sumba O, Doumbo OK, Koech D, Lancaster A, Nelson M, Meyer D, Single R, Hartzman R, Plowe CV, Kazura J, Mann D, Sztein M, Thomson G, Fernandez-Vina M. Differentiation between African populations is evidenced by the diversity of Alleles and Haplotypes of HLA class I Loci. Tissue Antigens 63:293-325, 2004.

40. Diallo D, Doumbo OK, Dicko A, Guindo A, Coulibaly D, Kayentao K, Djimde A, Thera M, Fairhurst R, Plowe CV, Wellems TE. A comparison of anemia in hemoglobin C and normal hemoglobin A children with Plasmodium falciparum malaria. Acta Tropica 90:295-299, 2004.

41. Lyke KE, Dicko A, Kone A, Coulibaly D, Guindo A, Cissoko Y, Traoré K, Plowe CV, Doumbo O. Incidence of severe Plasmodium falciparum malaria as a primary endpoint for vaccine efficacy trials in Bandiagara, Mali. Vaccine 22:3169-3174, 2004.

42. Djimde A, Dolo A, Ouattara A, Diakite S, Plowe CV, Doumbo OK. Molecular diagnosis of resistance to antimalarial drugs during epidemics and in war zones. Journal of Infectious Diseases 190:853-855, 2004.

43. Lyke KE, Burges R, Cissoko Y, Sangare L, Dao M, Diarra I, Kone A, Harley R, Plowe CV, Doumbo OK, Sztein M. Serum levels of pro-inflammatory cytokines interleukin-1 beta, IL-6, IL-8, IL-10, Tumor necrosis factor-alpha and IL-12p70 in Malian children with severe Plasmodium falciparum malaria and uncomplicated malaria or healthy controls. Infection and Immunity 72:5630-5637, 2004. PMCID: PMC517593.

44. Dzinjalamala FK, Macheso A, Kublin J, Taylor TE, Barnes K, Molyneux M, Plowe CV, Smith P. Blood folate concentrations and in vivo sulfadoxine-pyrimethamine failure in Malawian children with uncomplicated malaria. American Journal of Tropical Medicine & Hygiene 72:267-272, 2005.

45. Diallo D, Doumbo OK, Plowe CV, Wellems TE, Emanuel E, Hurst S. Community permission for medical research in developing countries. Clinical Infectious Diseases 41:255-259, 2005.

46. van Oosterhout J, Laufer MK, Graham S, Thumba F, Perez M, Chimbiya N, Wilson L, Chagomerana M, Molyneux M, Zijlstra E, Taylor TE, Plowe CV. A community-based study of the incidence of trimethoprim-sulfamethoxazole-preventable infections in Malawian adults living with HIV. Journal of Acquired Immune Deficiency Syndrome 39:626-631, 2005.

47. Lyke KE, Burges R, Cissoko Y, Sangare L, Kone A, Fernandez-Vina M, Plowe CV, Doumbo O, Sztein M. HLA-A2 supertype-restricted cell-mediated immunity by peripheral blood mononuclear cells derived from Malian children with severe or uncomplicated Plasmodium falciparum malaria and healthy controls. Infection and Immunity 73:5799-5808, 2005. PMCID: PMC1231120.

48. Dzinjalamala F, Macheso A, Kublin J, Taylor TE, Barnes K Molyneux M, Plowe CV, Smith P. Association between the pharmacokinetics and in vivo therapeutic efficacy of sulfadoxine-pyrimethamine in Malawian children. Antimicrobial Agents and Chemotherapy 49:3601-3606, 2005. PMCID: PMC1195435.

49. Thera M, Sehdev P, Coulibaly D, Traore K, Garba M, Cissoko Y, Kone A, Guindo A, Dicko A, Beavogui A, Djimde A, Lyke KE, Diallo D, Doumbo OK, Plowe CV. Impact of trimethoprim-sulfamethoxazole prophylaxis on falciparum malaria infection and disease. Journal of Infectious Diseases 192:1823-1829, 2005. PMCID: PMC2740817.

50. Lyke KE, Dicko A, Dabo A, Sangare L, Kone A, Coulibaly D, Guindo A, Traore K, Daou M, Diarra I, Sztein M, Plowe CV, Doumbo OK. Association of Schistosoma haematobium infection with protection against acute Plasmodium falciparum malaria in Malian children. American Journal of Tropical Medicine & Hygiene 73:1124-1130, 2005. PMCID: PMC2738948.

51. Laufer MK, van Oosterhout J, Thesing P, Thumba F, Zijlstra E, Graham S, Taylor T, Plowe CV. Impact of HIV-associated immunosuppression on malaria infection and disease in Malawi. Journal of Infectious Diseases 193:872-878, 2006.

52. Deans A, Lyke KE, Thera M, Plowe CV, Kone A, Doumbo OK, Kai O, Marsh K, Mackinnon M, Raza A, Rowe J. Low multiplication rates of African Plasmodium falciparum isolates and lack of association of multiplication rate and red blood cell selectivity with malaria virulence. American Journal of Tropical Medicine & Hygiene 74:554-563, 2006. PMCID: PMC2738946.

53. Takala SL, Smith D, Stine O, Coulibaly D, Thera M, Doumbo O, Plowe CV. A high-throughput method for quantifying alleles and haplotypes of the malaria vaccine candidate Plasmodium falciparum merozoite surface protein-1 19kDa. Malaria Journal 5:31, 2006. PMCID: PMC1459863.

54. Laufer MK, van Oosterhout J, Perez M, Kanyanganlika J, Taylor TE, Plowe CV, Graham S. Observational cohort study of HIV-infected African children. Pediatric Infectious Diseases Journal 25:623-627, 2006.

55. Cissoko Y, Daou M, Lyke KE, Dicko A, Diarra I, Kone A, Guindo A, Traore K, Krishnegowda G, Diallo D, Doumbo OK, Plowe CV, Gowda D, Sztein M. Glycosylphosphatidylinositols (GPIs) in specimens derived from matched Malian children with severe or uncomplicated Plasmodium falciparum malaria and health controls. American Journal of Tropical Medicine & Hygiene 75:199-204, 2006.

56. Lyke KE, Dabo A, Sangare L, Arama C, Daou M, Diarra I, Plowe CV, Doumbo OK, Sztein M. Effects of concomitant Schistosoma haematobium infection on the serum cytokine levels elicited by acute Plasmodium falciparum malaria infection in Malian children. Infection and Immunity 74:5718-5724, 2006. PMCID: PMC1594876.

57. Kyriacou H, Stone G, Challis R, Raza A, Lyke KE, Thera MA, Kone A, Doumbo OK, Plowe CV, Rowe J. Differential var gene transcription in Plasmodium falciparum isolates from patients with cerebral malaria compared to hyperparasitaemia. Molecular and Biochemical Parasitology 150:211-218, 2006. PMCID: PMC2176080.

58. Mendez F, Munoz A, Plowe CV. Use of area under the curve to characterize transmission potential after antimalarial treatment. American Journal of Tropical Medicine & Hygiene 75:640-644, 2006.

59. Laufer MK, Thesing PC, Eddington N, Masonga R, Dzinjalamala F, Takala SL, Taylor T, Plowe CV. Return of chloroquine anti-malaria efficacy in Malawi. New England Journal of Medicine 355:1959-1966, 2006.

60. Thera MA, Doumbo OK, Coulibaly D, Diallo D, Sagara I, Dicko A, Diemert D, Heppner Jr. DG, Stewart V, Angov E, Soisson L, Leach A, Tucker K, Lyke KE, Plowe CV and the Mali FMP1 Working Group. Randomized, double-blind controlled trial of the safety and allele-specific immunogenicity of the Plasmodium falciparum merozoite surface protein-142/AS02A malaria vaccine in Malian adults exposed to intense seasonal malaria. PLoS Clinical Trials 1:e34, 2006.

61. Rowe JA, Handel IG, Thera MA, Deans AM, Lyke KE, Kone A, Diallo DA, Raza A, Kai O, Marsh K, Plowe CV, Doumbo OK, Moulds JM. Blood group O protects against severe Plasmodium falciparum malaria through the mechanism of reduced rosetting. Proceedings of the National Academies of Science U S A 104:17471-17476, 2007. PMCID: PMC2077280.

62. van Oosterhout J, Laufer MK, Perez M, Graham S, Chimbiya N, Thesing PC, Alvarez-Martinez M, Wilson P, Chagomerana M, Zijlstra E, Taylor T, Plowe CV, Meshnick S. Pneumocystis pneumonia in HIV-positive adults, Malawi. Emerging Infectious Diseases 13:325-328, 2007. PMCID: PMC2725875.

63. Takala SL, Coulibaly D, Thera M, Dicko A, Smith D, Guindo A, Kone A, Ouattara A, Djimde A, Sehdev P. Lyke K, Diallo D, Doumbo OK, Plowe CV. Dynamics of polymorphism in a malaria vaccine antigen at a vaccine-testing site in Mali. PLoS Medicine 4:e93, 2007. PMCID: PMC1820605.

64. Djimde A, Kirkman L, Sassambara L, Diallo M, Plowe CV, Wellems TE, Doumbo OK. [In vitro cultivation of fields isolates of Plasmodium falciparum in Mali (in French)]. Bulletin Societe de Pathologie Exotique 100:3-5, 2007.

65. Takala SL, Smith D, Thera M, Coulibaly D, Doumbo OK, Plowe CV. Rare Plasmodium falciparum merozoite surface protein 1 19KDA (MSP119) haplotypes identified in Mali using high-throughput genotyping methods. American Journal of Tropical Medicine & Hygiene 76:855-859, 2007.

66. Mendez F, Herrera S, Murrain B, Gutierrez A, Moreno LA, Manzano M, Munoz A, Plowe CV. Selection of antifolate-resistant Plasmodium falciparum by sulfadoxine-pyrimethamine treatment and infectivity to Anopheles mosquitoes. American Journal of Tropical Medicine & Hygiene 77:438-443, 2007.

67. Arman M, Raza A, Tempest LJ, Lyke KE, Thera MA, Kone A, Plowe CV, Doumbo OK, Rowe JA. Platelet-mediated clumping of Plasmodium falciparum infected erythrocytes is associated with high parasitemia but not severe clinical manifestations of malaria in African children. American Journal of Tropical Medicine & Hygiene 77:943-946, 2007. PMCID: PMC2696181.

68. Laufer MK, van Oosterhout JJ, Thesing PC, Dzinjalamala FK, Hsi T, Beraho L, Graham SM, Taylor TE, Plowe CV. Malaria treatment efficacy among people living with HIV: the role of host and parasite factors. American Journal of Tropical Medicine & Hygiene 77:627-632, 2007.

69. Takala SL, Ouattara A, Coulibaly D, Thera MA, Dicko A, Guindo A, Kone A, Traore K, Djimde A, Lyke KE, Diallo DA, Doumbo OK, Plowe CV. Dynamics of polymorphism in Plasmodium falciparum apical membrane antigen-1 over three years at a vaccine-testing site in Mali. American Journal of Tropical Medicine & Hygiene 77:14, 2007.

70. Lyke KE, Dabo A, Arama C, Daou M, Diarra I, Plowe CV, Doumbo OK, Sztein M. Effects of concomitant Schistosoma haematobium infection on the intracellular cytokine levels and T Cell memory populations elicited by acute Plasmodium falciparum malaria infection in Malian children. American Journal of Tropical Medicine & Hygiene 77:324, 2007.

71. Thera MA, Doumbo OK, Coulibaly D, Diallo DA, Kone AK, Guindo AB, Traore K, Dicko A, Sagara I, Sissoko MS, Baby M, Sissoko M, Diarra I, Niangaly A, Dolo A, Daou M, Diawara SI, Heppner DG, Stewart VA, Angov E, Bergmann-Leitner ES, Lanar DE, Dutta S, Soisson L, Diggs CL, Leach A, Owusu A, Dubois MC, Cohen J, Nixon JN, Gregson A, Takala SL, Lyke KE, Plowe CV. Safety and immunogenicity of an AMA-1 malaria vaccine in Malian adults: Results of a Phase 1 randomized controlled trial. PLoS One 3:e1465, 2008. PMCID: PMC2186380.

72. Bell DJ, Nyirongo SK, Mukaka M, Zijlstra EE, Plowe CV, Molyneux ME, Ward SA, Winstanley PA. Sulfadoxine-pyrimethamine-based combinations for malaria: a randomised blinded trial to compare efficacy, safety and selection of resistance in Malawi. PLoS One. 3:e1578, 2008. PMCID: PMC2229666.

73. Malaria Genomic Epidemiology Network. A global network for investigating the genomic epidemiology of malaria. Nature 456:732-737, 2008. PMCID: PMC3758999.

74. Lyke KE, Daou M, Diarra I, Kone A, Kouriba B, Thera MA, Dutta S, Lanar DE, Heppner DG Jr, Doumbo OK, Plowe CV, Sztein MB. Cell-mediated immunity elicited by the blood stage malaria vaccine apical membrane antigen 1 in Malian adults: Results of a Phase I randomized trial. Vaccine 27:2171-2176, 2009. PMCID: PMC2707027.

75. Jallow M, Teo YY, Small KS, Rockett KA, Deloukas P, Clark TG, Kivinen K, Bojang KA, Conway DJ, Pinder M, Sirugo G, Sisay-Joof F, Usen S, Auburn S, Bumpstead SJ, Campino S, Coffey A, Dunham A, Fry AE, Green A, Gwilliam R, Hunt SE, Inouye M, Jeffreys AE, Mendy A, Palotie A, Potter S, Ragoussis J, Rogers J, Rowlands K, Somaskantharajah E, Whittaker P, Widden C, Donnelly P, Howie B, Marchini J, Morris A, Sanjoaquin M, Achidi EA, Agbenyega T, Allen A, Amodu O, Corran P, Djimde A, Dolo A, Doumbo OK, Drakeley C, Dunstan S, Evans J, Farrar J, Fernando D, Hien TT, Horstmann RD, Ibrahim M, Karunaweera N, Kokwaro G, Koram KA, Lemnge M, Makani J, Marsh K, Michon P, Modiano D, Molyneux ME, Mueller I, Parker M, Peshu N, Plowe CV, Puijalon O, Reeder J, Reyburn H, Riley EM, Sakuntabhai A, Singhasivanon P, Sirima S, Tall A, Taylor TE, Thera M, Troye-Blomberg M, Williams TN, Wilson M, Kwiatkowski DP; Wellcome Trust Case Control Consortium; Malaria Genomic Epidemiology Network. Genome-wide and fine-resolution association analysis of malaria in West Africa. Nature Genetics 41:657-665, 2009. PMCID: PMC2889040.

76. Takala SL, Coulibaly D, Thera MA, Batchelor AH, Cummings MP, Escalante AA, Ouattara A, Traore K, Niangaly A, Djimde AA, Doumbo OK, Plowe CV. Extreme polymorphism in a vaccine antigen and risk of clinical malaria: Implications for vaccine development. Science Translational Medicine 1:2ra5, 2009. PMCID: PMC2822345.

77. Coulibaly D, Rebaudet S, Travassos M, Tolo Y, Laurens M, Kone AK, Traore K, Guindo A, Diarra I, Niangaly A, Daou M, Dembele A, Sissoko M, Kouriba B, Dessay N, Gaudart J, Piarroux R, Thera MA, Plowe CV, Doumbo OK. Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali. Malaria Journal 12:82 2013. PMCID: PMC3618208.

78. Doumbo O, Thera M, Koné A, Raza A, Tempest L, Lyke K, Plowe C, Rowe J. High levels of Plasmodium falciparum rosetting in all clinical forms of severe malaria in African children. American Journal of Tropical Medicine & Hygiene 81:987-993, 2009. PMCID: PMC2877664.

79. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Kone AK, Guindo AB, Traore K, Sissoko M, Diallo DA, Diarra I, Kouriba B, Daou M, Dolo A, Baby M, Sissoko MS, Sagara I, Niangaly A, Traore I, Olotu A, Godeaux O, Leach A, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, Takala SL, Lyke KE, House B, Lanar DE, Dutta S, Heppner DG, Plowe CV. Safety and immunogenicity of an AMA1 malaria vaccine in Malian children: Results of a phase 1 randomized controlled trial. PLoS One 5:e9041, 2010. PMCID: PMC2816207.

80. Beavogui AH, Djimde AA, Gregson A, Toure AM, Dao A, Coulibaly B, Ouologuem D, Fofana B, Sacko A, Tekete M, Kone A, Niare O, Wele M, Plowe CV, Picot S, Doumbo OK. Low infectivity of Plasmodium falciparum gametocytes to Anopheles gambiae following treatment with sulfadoxine-pyrimethamine in Mali. International Journal of Parasitology 40:1213-1320, 2010. PMCID: PMC3571761.

81. Ouattara A, Mu J, Takala-Harrison S, Saye R, Sagara I, Dicko A, Niangaly A, Duan J, Ellis RD, Miller LH, Su XZ, Plowe CV, Doumbo OK. Lack of allele-specific efficacy of a bivalent AMA1 malaria vaccine. Malaria Journal 9:175, 2010. PMCID: PMC2908102.

82. Laufer MK, Takala-Harrison S, Dzinjalamala FK, Stine OC, Taylor TE, Plowe CV. Return of chloroquine-susceptible falciparum malaria in Malawi was a reexpansion of diverse susceptible parasites. Journal of Infectious Diseases 202:801-808, 2010. PMCID: PMC3380613.

83. Lyke KE, Laurens MB, Adams M, Billingsley PF, Richman A, Loyevsky M, Chakravarty S, Plowe CV, Sim BK, Edelman R, Hoffman SL. Plasmodium falciparum malaria challenge by the bite of aseptic Anopheles stephensi mosquitoes: Results of a randomized infectivity trial. PLoS One 5:e13490, 2010. PMCID: PMC2958836.

84. Lyke KE, Fernandez-Vina MA, Cao K, Hollenbach J, Coulibaly D, Kone AK, Guindo A, Burdett LA, Hartzman RJ, Wahl AR, Hildebrand WH, Doumbo OK, Plowe CV, Sztein MB. Association of HLA alleles with Plasmodium falciparum severity in Malian children. Tissue Antigens 77:562-571, 2011. PMCID: PMC3152196.

85. Epstein JE, Tewari K, Lyke KE, Sim BK, Billingsley PF, Laurens MB, Gunasekera A, Chakravarty S, James ER, Sedegah M, Richman A, Velmurugan S, Reyes S, Li M, Tucker K, Ahumada A, Ruben AJ, Li T, Stafford R, Eappen AG, Tamminga C, Bennett JW, Ockenhouse CF, Murphy JR, Komisar J, Thomas N, Loyevsky M, Birkett A, Plowe CV, Loucq C, Edelman R, Richie TL, Seder RA, Hoffman SL. Live attenuated malaria vaccine designed to protect through hepatic CD8+ T cell immunity. Science 334:475-480, 2011.

86. Thera MA, Doumbo OK, Coulibaly D, Laurens MB, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Thompson D, Dube T, Soisson L, Diggs CL, House B, Lanar DE, Dutta S, Heppner DG, Plowe, CV. A field trial to assess a blood-stage malaria vaccine. New England Journal of Medicine 365:1004-1013, 2011. PMCID: PMC3242358.

87. Mita T, Venkatesan M, Ohashi J, Culleton R, Takahashi N, Tsukahara T, Ndounga M, Dysoley L, Endo H, Hombhanje F, Ferreira MU, Plowe CV, Tanabe K. Limited geographical origin and global spread of sulfadoxine-resistant dhps alleles in Plasmodium falciparum populations. Journal of Infectious Diseases 201:1980-1988, 2011. PMCID: PMC3209816.

88. Venkatesan M, Amaratunga C, Campino S, Auburn S, Koch O, Lim P, Uk S, Socheat D, Kwiatkowski DP, Fairhurst RM, Plowe CV. Using CF11 cellulose columns to inexpensively and effectively remove human DNA from Plasmodium falciparum-infected whole blood samples. Malaria Journal 11:41, 2012. PMCID: PMC3295709.

89. Lyke KE, Dabo A, Arama C, Daou M, Diarra I, Wang A, Plowe CV, Doumbo OK, Sztein MB. Reduced T regulatory cell response during acute Plasmodium falciparum infection in Malian children co-infected with Schistosoma haematobium. PLoS One 7:e31647, 2012. PMCID: PMC3279404.

90. Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Doumbo OK, Takala-Harrison S, Plowe CV. Next generation sequencing to detect variation in the Plasmodium falciparum circumsporozoite protein. American Journal of Tropical Medicine & Hygiene 86:775-781, 2012. PMCID: PMC3335679.

91. Lyke KE, Wang A, Dabo A, Arama C, Daou M, Diarra I, Plowe CV, Doumbo OK, Sztein MB. Antigen-specific B memory cell responses to Plasmodium falciparum malaria antigens and Schistosoma haematobium antigens in co-infected Malian children. PLoS One. 7: e37868, 2012. PMCID: PMC3367916.

92. Shaukat AM, Gilliams EA, Kenefic LJ, Laurens MB, Dzinjalamala FK, Nyirenda OM, Thesing PC, Jacob CG, Molyneux ME, Taylor TE, Plowe CV, Laufer MK. Clinical manifestations of new versus recrudescent malaria infections following anti-malarial drug treatment. Malaria Journal 11:207, 2012. PMCID: PMC3489583.

93. Manske M, Miotto O, Campino S, Auburn S, Almagro-Garcia J, Maslen G, O'Brien J, Djimde A, Doumbo O, Zongo I, Ouedraogo JB, Michon P, Mueller I, Siba P, Nzila A, Borrmann S, Kiara SM, Marsh K, Jiang H, Su XZ, Amaratunga C, Fairhurst R, Socheat D, Nosten F, Imwong M, White NJ, Sanders M, Anastasi E, Alcock D, Drury E, Oyola S, Quail MA, Turner DJ, Ruano-Rubio V, Jyothi D, Amenga-Etego L, Hubbart C, Jeffreys A, Rowlands K, Sutherland C, Roper C, Mangano V, Modiano D, Tan JC, Ferdig MT, Amambua-Ngwa A, Conway DJ, Takala-Harrison S, Plowe CV, Rayner JC, Rockett KA, Clark TG, Newbold CI, Berriman M, MacInnis B, Kwiatkowski DP. Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing. Nature 487:375-379, 2012. PMCID: PMC3738909.

94. Maiga AW, Fofana B, Sagara I, Dembele D, Dara A, Traore OB, Toure S, Sanogo K, Dama S, Sidibe B, Kone A, Thera MA, Plowe CV, Doumbo OK, Djimde AA. No evidence of delayed parasite clearance after oral artesunate treatment of uncomplicated falciparum malaria in Mali. American Journal of Tropical Medicine & Hygiene 87:23-28, 2012. PMCID: PMC3391052.

95. Laufer MK, Thesing PC, Dzinjalamala FK, Nyirenda OM, Masonga R, Laurens MB, Stokes-Riner A, Taylor TE, Plowe CV. A longitudinal trial comparing chloroquine as monotherapy or in combination with artesunate, azithromycin or atovaquone-proguanil to treat malaria. PLoS One 7:e42284, 2012. PMCID: PMC3422316.

96. Ouattara A, Takala-Harrison S, Thera MA, Coulibaly D, Niangaly A, Saye R, Tolo Y, Dutta S, Heppner DG, Soisson L, Diggs CL, Vekemans J, Cohen J, Blackwelder WC, Dube T, Laurens MB, Doumbo OK, Plowe CV. Molecular basis of allele-specific efficacy of a blood-stage malaria vaccine: vaccine development implications. Journal of Infectious Diseases 207:511-519, 2013. PMCID: PMC3537449.

97. Takala-Harrison S, Clark TG, Jacob CG, Cummings MP, Miotto O, Dondorp AM, Fukuda MM, Nosten F, Noedl H, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Socheat D, Ariey F, Phyo AP, Starzengruber P, Fuehrer HP, Swoboda P, Stepniewska K, Flegg J, Arze C, Cerqueira GC, Silva JC, Ricklefs SM, Porcella SF, Stephens RM, Adams M, Kenefic LJ, Campino S, Auburn S, Macinnis B, Kwiatkowski DP, Su XZ, White NJ, Ringwald P, Plowe CV. Genetic loci associated with delayed clearance of Plasmodium falciparum following artemisinin treatment in Southeast Asia. Proceedings of the National Academy of Sciences USA 110:240-245, 2013. PMCID: PMC3538248.

98. Coulibaly D, Rebaudet S, Travassos M, Tolo Y, Laurens M, Kone AK, Traore K, Guindo A, Diarra I, Niangaly A, Daou M, Dembele A, Sissoko M, Kouriba B, Dessay N, Gaudart J, Piarroux R, Thera MA, Plowe CV, Doumbo OK. Spatio-temporal analysis of malaria within a transmission season in Bandiagara, Mali. Malaria Journal 12:82 2013. PMID: PMC3618208.

99. Miotto O, Almagro-Garcia J, Manske M, Macinnis B, Campino S, Rockett KA, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Duong S, Nguon C, Chuor CM, Saunders D, Se Y, Lon C, Fukuda MM, Amenga-Etego L, Hodgson AV, Asoala V, Imwong M, Takala-Harrison S, Nosten F, Su XZ, Ringwald P, Ariey F, Dolecek C, Hien TT, Boni MF, Thai CQ, Amambua-Ngwa A, Conway DJ, Djimdé AA, Doumbo OK, Zongo I, Ouedraogo JB, Alcock D, Drury E, Auburn S, Koch O, Sanders M, Hubbart C, Maslen G, Ruano-Rubio V, Jyothi D, Miles A, O'Brien J, Gamble C, Oyola SO, Rayner JC, Newbold CI, Berriman M, Spencer CC, McVean G, Day NP, White NJ, Bethell D, Dondorp AM, Plowe CV, Fairhurst RM, Kwiatkowski DP. Multiple populations of artemisinin-resistant Plasmodium falciparum in Cambodia. Nature Genetics 45:648-655, 2013. PMCID: PMC3807790.

100. Laurens MB, Billingsley P, Richman A, Eappen AG, Adams M, Li T, Chakravarty S, Gunasekera A, Jacob CG, Sim BK, Edelman R, Plowe CV, Hoffman SL, Lyke KE. Successful human infection with P. falciparum using three aseptic Anopheles stephensi Mosquitoes: A new model for Controlled Human Malaria Infection. PLoS One. 8:e68969, 2013. PMCID: PMC3712927.

101. Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly Dk, Laurens MB, Pablo J, Jasinskas A, Nakajima-Sasaki R, Berry AA, Takala-Harrison S, Kouriba B, Rowe JA, Lyke KE, Doumbo OK, Thera MA, Felgner PL, Plowe CV. Seroreactivity to Plasmodium falciparum erythrocyte membrane protein 1 intracellular domain in malaria-exposed children and adults. Journal of Infectious Diseases 208:1514-1519, 2013. PMCID: PMC: 3789569.

102. Seder RA, Chang LJ, Enama ME, Zephir KL, Sarwar UN, Gordon IJ, Holman LA, James ER, Billingsley PF, Gunasekera A, Richman A, Chakravarty S, Manoj A, Velmurugan S, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Plummer SH, Hendel CS, Novik L, Costner PJ, Mendoza FH, Saunders JG, Nason MC, Richardson JH, Murphy J, Davidson SA, Richie TL, Sedegah M, Sutamihardja A, Fahle GA, Lyke KE, Laurens MB, Roederer M, Tewari K, Epstein JE, Sim BK, Ledgerwood JE, Graham BS, Hoffman SL; VRC 312 Study Team. Protection against malaria by intravenous immunization with a nonreplicating sporozoite vaccine. Science 341:6152, 2013.

103. Khattak AA, Venkatesan M, Nadeem MF, Satti HS, Yaqoob A, Strauss K, Khatoon L, Malik SA, Plowe CV. Prevalence and distribution of human Plasmodium infection in Pakistan. Malaria Journal 12:297, 2013. PMCID: PMC3765785.

104. Khattak AA, Venkatesan M, Jacob CG, Artimovich EM, Nadeem MF, Nighat F, Hombhanje F, Mita T, Malik SA, Plowe CV. A comprehensive survey of polymorphisms conferring anti-malarial resistance in Plasmodium falciparum across Pakistan. Malaria Journal 12:300, 2013. PMCID: PMC3765786.

105. Khattak AA, Venkatesan M, Khatoon L, Ouattara A, Kenefic LJ, Nadeem MF, Nighat F, Malik SA, Plowe CV. Prevalence and patterns of antifolate and chloroquine drug resistance markers in Plasmodium vivax across Pakistan. Malaria Journal 12:310, 2013. PMCID: PMC3766695.

106. Laurens MB, Thera MA, Coulibaly D, Ouattara A, Kone AK, Guindo AB, Traore K, Traore I, Kouriba B, Diallo DA, Diarra I, Daou M, Dolo A, Tolo Y, Sissoko MS, Niangaly A, Sissoko M, Takala-Harrison S, Lyke KE, Wu Y, Blackwelder WC, Godeaux O, Vekemans J, Dubois MC, Ballou WR, Cohen J, Dube T, Soisson L, Diggs CL, House B, Bennett JW, Lanar DE, Dutta S, Heppner DG, Plowe CV, Doumbo OK. Extended safety, immunogenicity and efficacy of a blood-stage malaria vaccine in Malian children: 24-month follow-up of a randomized, double-blinded phase 2 trial. PLoS One 8:e79323, 2013. PMCID: PMC3832522.

107. Mita T, Ohashi J, Venkatesan M, Marma AS, Nakamura M, Plowe CV, Tanabe K. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite. Journal of Infectious Diseases 209:130-139, 2014.

108. Kayentao K, Guirou EA, Doumbo OK, Venkatesan M, Plowe CV, Parsons TL, Hendrix CW, Nyunt MM. Preliminary study of quinine pharmacokinetics in pregnant women with malaria-HIV co-infection. American Journal of Tropical Medicine & Hygiene 90:530-534, 2014. PMCID: PMC3945700.

109. Gilliams EA, Jumare J, Claassen CW, Thesing PC, Nyirenda OM, Dzinjalamala FK, Taylor T, Plowe CV, Tracy LA, Laufer MK. Chloroquine-azithromycin combination antimalarial treatment decreases risk of respiratory and gastrointestinal tract infections in Malawian children. Journal of Infectious Diseases 210:585-592, 2014. PMCID: PMC4172042.

110. Frosch AE, Laufer MK, Mathanga DP, Takala-Harrison S, Skarbinski J, Claassen CW, Dzinjalamala FK, Plowe CV. Return of widespread chloroquine-sensitive Plasmodium falciparum to Malawi. Journal of Infectious Diseases 210:1110-1114, 2014.

111. Murphy SC, Hermsen CC, Douglas AD, Edwards NJ, Petersen I, Fahle GA, Adams M, Berry AA, Billman ZP, Gilbert SC, Laurens MB, Leroy O, Lyke KE, Plowe CV, Seilie AM, Strauss KA, Teelen K, Hill AV, Sauerwein RW. External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance. PLoS One 9:e97398, 2014. PMCID: PMC4023973.

112. Gandhi K, Thera MA, Coulibaly D, Traoré K, Guindo AB, Ouattara A, Berry AA, Takala-Harrison S, Doumbo OK, Plowe CV. Variation in the circumsporozoite protein of Plasmodium falciparum: vaccine development implications: Genetic variation in a malaria vaccine antigen. PLOS One 9:e101783, 2014. PMCID: PMC4081809.

113. Ashley EA, Dhorda M, Fairhurst RM, Amaratunga C, Lim P, Suon S, Sreng S, Anderson JM, Mao S, Sam B, Sopha C, Chuor CM, Nguon C, Sovannaroth S, Pukrittayakamee S, Jittamala P, Chotivanich K, Chutasmit K, Suchatsoonthorn C, Runcharoen R, Hien TT, Thuy-Nhien NT, Thanh NV, Phu NH, Htut Y, Han KT, Aye KH, Mokuolu OA, Olaosebikan RR, Folaranmi OO, Mayxay M, Khanthavong M, Hongvanthong B, Newton PN, Onyamboko MA, Fanello CI, Tshefu AK, Mishra N, Valecha N, Phyo AP, Nosten F, Yi P, Tripura R, Borrmann S, Bashraheil M, Peshu J, Faiz MA, Ghose A, Hossain MA, Samad R, Rahman MR, Hasan MM, Islam A, Miotto O, Amato R, MacInnis B, Stalker J, Kwiatkowski DP, Bozdech Z, Jeeyapant A, Cheah PY, Sakulthaew T, Chalk J, Intharabut B, Silamut K, Lee SJ, Vihokhern B, Kunasol C, Imwong M, Tarning J, Taylor WJ, Yeung S, Woodrow CJ, Flegg JA, Das D, Smith J, Venkatesan M, Plowe CV, Stepniewska K, Guerin PJ, Dondorp AM, Day NP, White NJ; Tracking Resistance to Artemisinin Collaboration (TRAC). Spread of artemisinin resistance in Plasmodium falciparum malaria. New England Journal of Medicine 371:411-423, 2014. PMCID: PMC4143591.

114. Shekalaghe S, Rutaihwa M, Billingsley PF, Chemba M, Daubenberger CA, James ER, Mpina M, Ali Juma O, Schindler T, Huber E, Gunasekera A, Manoj A, Simon B, Saverino E, Church LW, Hermsen CC, Sauerwein RW, Plowe C, Venkatesan M, Sasi P, Lweno O, Mutani P, Hamad A, Mohammed A, Urassa A, Mzee T, Padilla D, Ruben A, Sim BK, Tanner M, Abdulla S, Hoffman SL. Controlled human malaria infection of Tanzanians by intradermal injection of aseptic, purified, cryopreserved Plasmodium falciparum sporozoites. American Journal of Tropical Medicine & Hygiene 91:471-880, 2014. PMCID: PMC4155546.

115. Venkatesan M, Gadalla NB, Stepniewska K, Dahal P, Nsanzabana C, Moriera C, Price RN, Mårtensson A, Rosenthal PJ, Dorsey G, Sutherland CJ, Guérin P, Davis TM, Ménard D, Adam I, Ademowo G, Arze C, Baliraine FN, Berens-Riha N, Björkman A, Borrmann S, Checchi F, Dhorda MD, Djimdé AA, El-Sayed BB, Eshetu T, Eyase F, Falade C, Faucher JF, Fröberg G, Grivoyannis A, Hamour S, Houzé S, Johnson J, Kamugisha E, Kariuki S, Kiechel JR, Kironde F, LeBras PE, Malmberg M, Mwai L, Ngasala B, Nosten F, Nsobya SL, Oguike AN, Otienoburu SD, Ogutu B, Ouédraogo JB, Piola P, Rombo L, Schramm B, Somé AF, Thwing J, Ursing J, Wong RP, Zeynudin A, Zongo I, Plowe CV, Sibley CH. Polymorphisms in Plasmodium falciparum chloroquine resistance transporter and multidrug resistance 1 genes: parasite risk factors that affect treatment outcomes for P. falciparum malaria after artemether-lumefantrine and artesunate-amodiaquine. American Journal of Tropical Medicine & Hygiene 91:833-843, 2014. PMCID: PMC4183414.

116. Jacob CG, Tan JC, Miller BA, Tan A, Takala-Harrison S, Ferdig MT, Plowe CV. A microarray platform and novel SNP calling algorithm to evaluate Plasmodium falciparum field samples of low DNA quantity. BMC Genomics 15:719, 2014. PMCID: PMC4153902.

117. Takala-Harrison S, Jacob CG, Arze C, Cummings MP, Silva JC, Dondorp AM, Fukuda MM, Hien TT, Mayxay M, Noedl H, Nosten F, Kyaw MP, Nhien NT, Imwong M, Bethell D, Se Y, Lon C, Tyner SD, Saunders DL, Ariey F, Mercereau-Puijalon O, Menard D, Newton PN, Khanthavong M, Hongvanthong B, Starzengruber P, Fuehrer HP, Swoboda P, Khan WA, Phyo AP, Nyunt MM, Nyunt MH, Brown TS, Adams M, Pepin CS, Bailey J, Tan JC, Ferdig MT, Clark TG, Miotto O, MacInnis B, Kwiatkowski DP, White NJ, Ringwald P, Plowe CV. Independent emergence of Plasmodium falciparum artemisinin resistance mutations in Southeast Asia. Journal of Infectious Diseases 211:670-79, 2014. PMCID: PMC4334802.

118. Coulibaly D, Travassos MA, Kone AK, Tolo Y, Laurens MB, Traore K, Diarra I, Niangaly A, Daou M, Dembele A, Sissoko M, Guindo B, Douyon R, Guindo A, Kouriba B, Sissoko MS, Sagara I, Plowe CV, Doumbo OK, Thera MA. Stable malaria incidence despite scaling up control strategies in a malaria vaccine testing site in Mali. Malaria Journal 13:374, 2014. PMCID: PMC4180968.

119. Bailey JA, Pablo J, Niangaly A, Travassos MA, Ouattara A, Coulibaly D, Laurens MB, Takala-Harrison SL, Lyke KE, Skinner J, Berry AA, Jasinskas A, Nakajima-Sasaki R, Kouriba B, Thera MA, Felgner PL, Doumbo OK, Plowe CV. Seroreactivity to a large panel of field-derived Plasmodium falciparum apical membrane antigen 1 and merozoite surface protein 1 variants reflects seasonal and lifetime acquired responses to malaria. . American Journal of Tropical Medicine & Hygiene 92:9-12, 2015. PMCID: PMC4347399.

120. Brown TS, Jacob CG, Silva JC, Takala-Harrison S, Djimdé A, Dondorp AM, Fukuda M, Noedl H, Nyunt MM, Kyaw MP, Mayxay M, Hien TT, Plowe CV, Cummings MP. Plasmodium falciparum field isolates from areas of repeated emergence of drug resistant malaria show no evidence of hypermutator phenotype. Infection, Genetics and Evolution 30:318-322, 2015. PMCID: PMC4316729.

121. Miotto O, Amato R, Ashley EA, MacInnis B, Almagro-Garcia J, Amaratunga C, Lim P, Mead D, Oyola SO, Dhorda M, Imwong M, Woodrow C, Manske M, Stalker J, Drury E, Campino S, Amenga-Etego L, Thanh TN, Tran HT, Ringwald P, Bethell D, Nosten F, Phyo AP, Pukrittayakamee S, Chotivanich K, Chuor CM, Nguon C, Suon S, Sreng S, Newton PN, Mayxay M, Khanthavong M, Hongvanthong B, Htut Y, Han KT, Kyaw MP, Faiz MA, Fanello CI, Onyamboko M, Mokuolu OA, Jacob CG, Takala-Harrison S, Plowe CV, Day NP, Dondorp AM, Spencer CC, McVean G, Fairhurst RM, White NJ, Kwiatkowski DP. Genetic architecture of artemisinin-resistant Plasmodium falciparum. Nature Genetics 47:226-234, 2015. PMCID: PMC4545236.

122. Artimovich E, Schneider K, Taylor TE, Kublin JG, Dzinjalamala FK, Escalante AA, Plowe CV, Laufer MK, Takala-Harrison S. Persistence of sulfadoxine-pyrimethamine resistance despite reduction of drug pressure in Malawi. Journal of Infectious Diseases 212:694-701, 2015. PMCID: PMC4539899.

123. White LJ, Flegg JA, Phyo AP, Wiladpai-Ngern JH, Bethell D, Plowe C, Anderson T, Nkhoma S, Nair S, Tripura R, Stepniewska K, Pan-Ngum W, Silamut K, Cooper BS, Lubell Y, Ashley EA, Nguon C, Nosten F, White NJ, Dondorp AM. Defining the in vivo phenotype of artemisinin-resistant falciparum malaria: a modeling approach. PLoS Medicine 2:e1001823, 2015. PMCID: PMC4412633.

124. Ouattara A, Kone A, Adams M, Fofana B, Maiga AW, Hampton S, Coulibaly D, Thera MA, Diallo N, Dara A, Sagara I, Gil JP, Bjorkman A, Takala-Harrison S, Doumbo OK, Plowe CV, Djimde AA. Polymorphisms in the K13-propeller gene in artemisinin susceptible Plasmodium falciparum parasites from Bougoula-Hameau and Bandiagara, Mali. American Journal of Tropical Medicine & Hygiene 92:1202-1206, 2015. PMCID PMC4458826.

125. Travassos MA, Coulibaly D, Bailey JA, Niangaly A, Adams M, Nyunt MM, Ouattara A, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima-Sasaki R, Berry AA, Takala-Harrison S, Kone AK, Kouriba B, Rowe JA, Doumbo OK, Thera MA, Laufer MK, Felgner PL, Plowe CV. Differential recognition of terminal extracellular Plasmodium falciparum VAR2CSA domains by Sera from multigravida, malaria-exposed Malian women. American Journal of Tropical Medicine & Hygiene 92:1190-1194, 2015. PMCID: PMC4458824.

126. Huang F, Takala-Harrison S, Jacob CG, Liu H, Sun X, Yang H, Nyunt MM, Adams M, Zhou S, Xia Z, Ringwald P, Bustos MD, Tang L, Plowe CV. A single mutation in K13 predominates in southern China and is associated with delayed clearance of Plasmodium falciparum following artemisinin treatment. Journal of Infectious Diseases 212:1629-1635, 2015. PMCID: PMC4621243.

127. Chaorattanakawee S, Saunders DL, Sea D, Chanarat N, Yingyuen K, Sundrakes S, Saingam P, Buathong N, Sriwichai S, Chann S, Se Y, Yom Y, Heng TK, Kong N, Kuntawunginn W, Tangthongchaiwiriya K, Jacob C, Takala-Harrison S, Plowe C, Lin JT, Chuor CM, Prom S, Tyner SD, Gosi P, Teja-Isavadharm P, Lon C, Lanteri CA. Ex vivo drug susceptibility and molecular profiling of clinical Plasmodium falciparum isolates from Cambodia in 2008-2013 suggest emerging piperaquine resistance. Antimicrobial Agents and Chemotherapy 59:4631-4643, 2015. PMCID: PMC4505231.

128. Travassos MA, Coulibaly D, Laurens MB, Dembélé A, Tolo Y, Koné AK, Traoré K, Niangaly A, Guindo A, Wu Y, Berry AA, Jacob CG, Takala-Harrison S, Adams M, Shrestha B, Mu AZ, Kouriba B, Lyke KE, Diallo DA, Doumbo OK, Plowe CV, Thera MA. Hemoglobin C Trait provides protection from clinical falciparum malaria in Malian children. Journal of Infectious Diseases 212:1778-1786, 2015. PMCID: PMC4633765.

129. Lyke KE, Laurens MB, Strauss K, Adams M. Billingsley PF, James E, Manoj A, Chakravarty S, Plowe CV, Li ML, Ruben A, Edelman R, Green M, Dube TJ, Sim BK, Hoffman SL. Optimizing intradermal administration of cryopreserved Plasmodium falciparum sporozoites in Controlled Human Malaria Infection. American Journal of Tropical Medicine & Hygiene 93:1274-12184, 2015. PMCID: PMC4674246.

130. Adams M, Joshi SN, Mbambo G, Mu ZA, Roemmich SM, Shrestha B, Strauss KA, Johnson NE, Oo KZ, Hlaing TM, Han ZY, Han KT, Thura S, Richards AK, Huang F, Nyunt MM, Plowe CV. An ultrasensitive reverse transcription polymerase chain reaction assay to detect asymptomatic low-density Plasmodium falciparum and Plasmodium vivax infections in small volume blood samples. Malaria Journal 14:520, 2015. PMCID: PMC4690410.

131. MalariaGEN Plasmodium falciparum Community Project. Genomic epidemiology of artemisinin resistant malaria. Elife 5:e08714, 2016. PMCID: PMC4786412

132. Sobota RS, Dara A, Manning JE, Niangaly A, Bailey JA, Kone AK, Thera MA, Djimdé AA, Vernet G, Leissner P, Williams SM, Plowe CV, and Doumbo OK. Expression of complement and toll-like receptor pathway genes is associated with malaria severity in Mali: a pilot case control study. Malaria Journal 15:150, 2016. PMCID: PMC4784286.

133. Graves SF, Kouriba B, Diarra I, Daou M, Niangaly A, Coulibaly D, Keita Y, Laurens MB, Berry AA, Vekemans J, Ripley Ballou W, Lanar DE, Dutta S, Gray Heppner D, Soisson L, Diggs CL, Thera MA, Doumbo OK, Plowe CV, Sztein MB, Lyke KE. Strain-specific Plasmodium falciparum multifunctional CD4+ T cell cytokine expression in Malian children immunized with the FMP2.1/AS02A vaccine candidate. Vaccine 34:2546-2555, 2016.

134. Ishizuka AS, Lyke KE, DeZure A, Berry AA, Richie TL, Mendoza FH, Enama ME, Gordon IJ, Chang LJ, Sarwar UN, Zephir KL, Holman LA, James ER, Billingsley PF, Gunasekera A, Chakravarty S, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, K C N, Murshedkar T, DeCederfelt H, Plummer SH, Hendel CS, Novik L, Costner PJ, Saunders JG, Laurens MB, Plowe CV, Flynn B, Whalen WR, Todd JP, Noor J, Rao S, Sierra-Davidson K, Lynn GM, Epstein JE, Kemp MA, Fahle GA, Mikolajczak SA, Fishbaugher M, Sack BK, Kappe SH, Davidson SA, Garver LS, Björkström NK, Nason MC, Graham BS, Roederer M, Sim BK, Hoffman SL, Ledgerwood JE, Seder RA. Protection against malaria at 1 year and immune correlates following PfSPZ vaccination. Nature Medicine 22:614-23, 2016.

135. Laurens MB, Mungwira RG, Nyirenda OM, Divala TH, Kanjala M, Muwalo F, Mkandawire FA, Tsirizani L, Nyangulu W, Mwinjiwa E, Taylor TE, Mallewa J, Blackwelder WC, Plowe CV, Laufer MK, van Oosterhout JJ. TSCQ study: a randomized, controlled, open-label trial of daily trimethoprim-sulfamethoxazole or weekly chloroquine among adults on antiretroviral therapy in Malawi: study protocol for a randomized controlled trial. Trials. 17:322, 2016. PMCID: PMC4950772.

136. Busby GB, Band G, Si Le Q, Jallow M, Bougama E, Mangano VD, Amenga-Etego LN, Enimil A, Apinjoh T, Ndila CM, Manjurano A, Nyirongo V, Doumbo O, Rockett KA, Kwiatkowski DP, Spencer CC; Malaria Genomic Epidemiology Network. Admixture into and within sub-Saharan Africa. Elife 5 e15266, 2016. PMCID: PMC4915815.

137. Lyke KE, Ishizuka AS, Berry AA, Chakravarty S, DeZure A, Enama ME, James ER, Billingsley PF, Gunasekera A, Manoj A, Li M, Ruben AJ, Li T, Eappen AG, Stafford RE, Kc N, Murshedkar T, Mendoza FH, Gordon IJ, Zephir KL, Holman LA, Plummer SH, Hendel CS, Novik L, Costner PJ, Saunders JG, Berkowitz NM, Flynn BJ, Nason MC, Garver LS, Laurens MB, Plowe CV, Richie TL, Graham BS, Roederer M, Sim BK, Ledgerwood JE, Hoffman SL, Seder RA. Attenuated PfSPZ Vaccine induces strain-transcending T cells and durable protection against heterologous controlled human malaria infection. Proceedings of the National Academy of Sciences USA 114:2711-2716, 2017.

138. Laurens MB, Kouriba B, Bergmann-Leitner E, Angov E, Coulibaly D, Diarra I, Daou M, Niangaly A, Blackwelder WC, Wu Y, Cohen J, Ballou WR, Vekemans J, Lanar DE, Dutta S, Diggs C, Soisson L, Heppner DG, Doumbo OK, Plowe CV, Thera MA. Strain-specific Plasmodium falciparum growth inhibition among Malian children immunized with a blood-stage malaria vaccine. PLoS One 12:e0173294, 2017. PMCID: PMC5345808.

139. Dara A, Drábek EF, Travassos MA, Moser KA, Delcher AL, Su Q, Hostelley T, Coulibaly D, Daou M, Dembele A, Diarra I, Kone AK, Kouriba B, Laurens MB, Niangaly A, Traore K, Tolo Y, Fraser CM, Thera MA, Djimde AA, Doumbo OK, Plowe CV, Silva JC. New var reconstruction algorithm exposes high var sequence diversity in a single geographic location in Mali. Genome Medicine 9:30, 2017. PMCID: PMC5368897.

140. Niangaly A, Karthigayan Gunalan, Amed Ouattara, Coulibaly D, Sá JM, Adams M, Travassos MA, Ferrero J, Laurens MB, Kone AK, Thera MA, Plowe CV, Miller LH, Doumbo OK. Plasmodium vivax infections over 3 years in Duffy blood group negative Malians in Bandiagara, Mali. American Journal of Tropical Medicine & Hygiene 97:744-752, 2017.

141. Dara A, Travassos MA, Adams M, Schaffer DeRoo S, Drábek EF, Agrawal S, Laufer MK, Plowe CV, Silva JC. A new method for sequencing the hypervariable Plasmodium falciparum gene var2csa from clinical samples. Malaria Journal 16:343, 2017. PMCID: PMC5561619.

142. Boudová S, Walldorf JA, Bailey JA, Divala T, Mungwira R, Mawindo P, Pablo J, Jasinskas A, Nakajima R, Ouattara A, Adams M, Felgner PL, Plowe CV, Travassos MA, Laufer MK. Mother-newborn pairs in Malawi have similar antibody repertoires to diverse malaria antigens. Clinical Vaccines & Immunology 24:e00136-17, 2017. PMCID: PMC5629668.

143. Zainabadi K, Adams M, Han ZY, Lwin HW, Han KT, Ouattara A, Thura S, Plowe CV, Nyunt MM. A novel method for extracting nucleic acids from dried blood spots for ultrasensitive detection of low-density Plasmodium falciparum and Plasmodium vivax infections. Malaria Journal 16:377, 2017. PMCID: PMC5604154.

144. Agrawal S, Moser KA, Morton L, Cummings MP, Parihar A, Dwivedi A, Shetty AC, Drabek EF, Jacob CG, Henrich PP, Parobek CM, Jongsakul K, Huy R, Spring MD, Lanteri CA, Chaorattanakawee S, Lon C, Fukuda MM, Saunders DL, Fidock DA, Lin JT, Juliano JJ, Plowe CV, Silva JC, Takala-Harrison S. Association of a novel mutation in the Plasmodium falciparum Chloroquine Resistance Transporter with decreased piperaquine sensitivity. Journal of Infectious Diseases 216:468-476, 2017. PMCID: PMC5853219.

145. Huang F, Takala-Harrison S, Liu H, Xu JW, Yang HL, Adams M, Shrestha B, Mbambo G, Rybock D, Zhou SS, Xia ZG, Zhou XN, Plowe CV, Nyunt MM. Prevalence of clinical and subclinical Plasmodium falciparum and Plasmodium vivax malaria in two remote rural communities on the Myanmar-China border. American Journal of Tropical Medicine & Hygiene 97:1524-1531, 2017. PMCID: PMC5817756.

146. Coulibaly D, Travassos MA, Tolo Y, Laurens MB, Kone AK, Traore K, Sissoko M, Niangaly A, Diarra I, Daou M, Guindo B, Rebaudet S, Kouriba B, Dessay N, Piarroux R, Plowe CV, Doumbo OK, Thera MA, Gaudart J. Spatio-temporal dynamics of asymptomatic malaria: Bridging the gap between annual malaria resurgences in a Sahelian environment. American Journal of Tropical Medicine & Hygiene 97:1761-1769, 2017. PMCID: PMC5805033.

147. Taghavian O, Jain A, Joyner CJ, Ketchum S, Nakajima R, Jasinskas A, Liang L, Fong R, King C, Greenhouse B, Murphy M, Bailey J, Galinski MR, Barnwell JW, Plowe CV, Davies DH, Felgner PL. Antibody profiling by proteome microarray with multiplex isotype detection reveals overlap between human and Aotus nancymaae controlled malaria infections. Proteomics 18:e1870115, 2018.

148. Arama C, Diarra I, Kouriba B, Sirois F, Fedoryak O, Thera MA, Coulibaly D, Lyke KE, Plowe CV, Chrétien M, Doumbo OK, Mbikay M. Malaria severity: Possible influence of the E670G PCSK9 polymorphism: A preliminary case-control study in Malian children. PLoS One. 13:e0192850, 2018. PMID: 29447211.

149. Lyke KE, Dabo A, Arama C, Diarra I, Plowe CV, Doumbo OK, Sztein MB. Long-term Maintenance of CD4 T cell memory responses to malaria antigens in Malian children coinfected with Schistosoma haematobium. Frontiers in Immunology 8:1995, 2018. PMCID: PMC5799235.

150. Travassos MA, Niangaly A, Bailey JA, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Pablo J, Jasinskas A, Nakajima R, Berry AA, Adams M, Jacob CG, Pike A, Takala-Harrison S, Liang L, Kouriba B, Kone AK, Rowe JA, Moulds J, Diallo DA, Doumbo OK, Thera MA, Felgner PL, Plowe CV. Children with cerebral malaria or severe malarial anaemia lack immunity to distinct variant surface antigen subsets. Scientific Reports, 8:6281, 2018. PMCID: PMC5908851.

151. Opi DH, Swann O, Macharia A, Uyoga S, Band G, Ndila CM, Harrison EM, Thera MA, Kone AK, Diallo DA, Doumbo OK, Lyke KE, Plowe CV, Moulds JM, Shebbe M, Mturi N, Peshu N, Maitland K, Raza A, Kwiatkowski DP, Rockett KA, Williams TN, Rowe JA. Two complement receptor one alleles have opposing associations with cerebral malaria and interact with α(+)thalassaemia. Elife 7:e31579, 2018. PMCID: PMC5953541.

152. Ouattara A, Tran TM, Doumbo S, Adams M, Agrawal S, Niangaly A, Nelson-Owens S, Doumtabé D, Tolo Y, Ongoiba A, Takala-Harrison S, Traoré B, Silva JC, Crompton PD, Doumbo OK, Plowe CV. Extent and dynamics of polymorphism in the malaria vaccine candidate Plasmodium falciparum Reticulocyte-Binding Protein Homologue-5 in Kalifabougou, Mali. American Journal of Tropical Medicine & Hygiene 99:43-50, 2018. PMID: 29848401.

153. Taghavian O, Jain A, Joyner CJ, Ketchum S, Nakajima R, Jasinskas A, Liang L, Fong R, King C, Greenhouse B, Murphy M, Bailey J, Galinski MR, Barnwell JW, Plowe CV, Davies DH, Felgner PL. Antibody profiling by proteome microarray with multiplex isotype detection reveals overlap between human and Aotus nancymaae controlled malaria infections. Proteomics 18:e1870115, 2018. PMID: 29963771.

154. Ndila CM, Uyoga S, Macharia AW, Nyutu G, Peshu N, Ojal J, Shebe M, Awuondo KO, Mturi N, Tsofa B, Sepúlveda N, Clark TG, Band G, Clarke G, Rowlands K, Hubbart C, Jeffreys A, Kariuki S, Marsh K, Mackinnon M, Maitland K, Kwiatkowski DP, Rockett KA, Williams TN; MalariaGEN Consortium. Human candidate gene polymorphisms and risk of severe malaria in children in Kilifi, Kenya: a case-control association study. Lancet Haematology 5:e333-e345, 2018. PMID: 30033078.

155. WWARN K13 Genotype-Phenotype Study Group. Association of mutations in the Plasmodium falciparum Kelch13 gene (Pf3D7_1343700) with parasite clearance rates after artemisinin-based treatments-a WWARN individual patient data meta-analysis. BMC Medicine 17:1, 2019. PMID: 30651111.

156. Berry AA, Gottlieb ER, Kouriba B, Diarra I, Thera MA, Dutta S, Coulibaly D, Ouattara A, Niangaly A, Kone AK, Traore K, Tolo Y, Mishcherkin V, Soisson L, Diggs CL, Blackwelder WC, Laurens MB, Sztein MB, Doumbo OK, Plowe CV, Lyke KE. Immunoglobulin G subclass and antibody avidity responses in Malian children immunized with Plasmodium falciparum apical membrane antigen 1 vaccine candidate FMP2.1/AS02(A). Malaria Journal 18:13, 2019. PMID: 30658710.

157. Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Agrawal S, Stucke EM, Ouattara A, Coulibaly D, Lyke KE, Laurens MB, Adams M, Takala-Harrison S, Pablo J, Jasinskas A, Nakajima R, Niangaly A, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Thera MA, Patel JJ, Tan JC, Felgner PL, Plowe CV, Travassos MA. Antibodies to peptides in semiconserved domains of RIFINs and STEVORs correlate with malaria exposure. mSphere 4:e00097-19, 2019. PMID: 30894432.

158. Seilie AM, Chang M, Hanron AE, Billman ZP, Stone BC, Zhou K, Olsen TM, Daza G, Ortega J, Cruz KR, Smith N, Healy SA, Neal J, Wallis CK, Shelton L, Mankowski TV, Wong-Madden S, Mikolajczak SA, Vaughan AM, Kappe SHI, Fishbaugher M, Betz W, Kennedy M, Hume JCC, Talley AK, Hoffman SL, Chakravarty S, Sim BKL, Richie TL, Wald A, Plowe CV, Lyke KE, Adams M, Fahle GA, Cowan EP, Duffy PE, Kublin JG, Murphy SC. Beyond blood smears: qualification of Plasmodium 18S rNA as a biomarker for controlled human malaria infections. American Journal of Tropical Medicine & Hygiene 100:1466-1476, 2019. PMID: 31017084.

159. Zainabadi K, Nyunt MM, Plowe CV. An improved nucleic acid extraction method from dried blood spots for amplification of Plasmodium falciparum kelch13 for detection of artemisinin resistance. Malaria Journal 18:192, 2019. PMID: 31185976.

160. Shetty AC, Jacob CG, Huang F, Li Y, Agrawal S, Saunders DL, Lon C, Fukuda MM, Ringwald P, Ashley EA, Han KT, Hlaing TM, Nyunt MM, Silva JC, Stewart KE, Plowe CV, O’Connor TD, Takala-Harrison S. Artemisinin resistance confirmation, characterization, and containment (ARC3); artemisinin resistance containment and elimination (ARCE); tracking resistance to artemisinin collaboration (TRAC). Nature Communications 10:2665, 2019. PMID: 31209259.

161. WorldWide Antimalarial Resistance Network Methodology Study Group. Competing risk events in antimalarial drug trials in uncomplicated Plasmodium falciparum malaria: A WorldWide Antimalarial Resistance Network individual participant data meta-analysis. Malaria Journal 18:225, 2019. PMID: 31277713.

162. Stucke EM, Niangaly A, Berry AA, Bailey JA, Coulibaly D, Ouattara A, Lyke KE, Laurens MB, Dara A, Adams M, Pablo J, Jasinskas A, Nakajima R, Zhou AE, Agrawal S, Friedman-Klabanoff DJ, Takala-Harrison S, Kouriba B, Kone AK, Rowe JA, Doumbo OK, Felgner PL, Thera MA, Plowe CV, Travassos MA. Serologic responses to thePfEMP1 DBL-CIDR head structure may be a better indicator of malaria exposure than those to the DBL-α tag. Malaria Journal 18:273, 2019. PMID: 31409360.

163. Laurens MB, Berry AA, Travassos MA, Strauss K, Adams M, Shrestha B, Li T, Eappen A, Manoj A, Abebe Y, Murshedkar T, Gunasekera A, Richie TL, Lyke KE, Plowe CV, Kennedy JK, Potter GE, Deye GA, Sim BKL, Hoffman SL. Dose-dependent infectivity of aseptic, purified, cryopreserved Plasmodium falciparum 7G8 sporozoites in malaria-naive adults. Journal of Infectious Diseases 220:1962-1966, 2019. PMID: 31419294.

164. Han KT, Lin K, Myint MK, Thi A, Aye KH, Han ZY, Moe M, Bustos MD, Rahman MM, Ringwald P, Simmons R, Markwalter CF, Plowe CV, Nyunt MM. Artemether-lumefantrine and dihydroartemisinin-piperaquine retain high efficacy for treatment of uncomplicated Plasmodium falciparum malaria in Myanmar. American Journal of Tropical Medicine & Hygiene 102:598-604, 2020. PMID: 31833468.

165. Moser KA, Drábek EF, Dwivedi A, Stucke EM, Crabtree J, Dara A, Shah Z, Adams M, Li T, Rodrigues PT, Koren S, Phillippy AM, Munro JB, Ouattara A, Sparklin BC, Dunning Hotopp JC, Lyke KE, Sadzewicz L, Tallon LJ, Spring MD, Jongsakul K, Lon C, Saunders DL, Ferreira MU, Nyunt MM, Laufer MK, Travassos MA, Sauerwein RW, Takala-Harrison S, Fraser CM, Sim BKL, Hoffman SL, Plowe CV, Silva JC. Strains used in whole organism Plasmodium falciparum vaccine trials differ in genome structure, sequence, and immunogenic potential. Genome Medicine 12:6, 2020. PMID: 31915075.

166. Bailey JA, Berry AA, Travassos MA, Ouattara A, Boudova S, Dotsey EY, Pike A, Jacob CG, Adams M, Tan JC, Bannen RM, Patel JJ, Pablo J, Nakajima R, Jasinskas A, Dutta S, Takala-Harrison S, Lyke KE, Laurens MB, Niangaly A, Coulibaly D, Kouriba B, Doumbo OK, Thera MA, Felgner PL, Plowe CV. Microarray analyses reveal strain-specific antibody responses to Plasmodium falciparum apical membrane antigen 1 variants following natural infection and vaccination. Scientific Reports 10:3952, 2020. PMID: 32127565.

167. Li Y, Shetty AC, Lon C, Spring M, Saunders DL, Fukuda MM, Hien TT, Pukrittayakamee S, Fairhurst RM, Dondorp AM, Plowe CV, O'Connor TD, Takala-Harrison S, Stewart K. Detecting geospatial patterns of Plasmodium falciparum parasite migration in Cambodia using optimized estimated effective migration surfaces. International Journal of Health Geographics 19:13, 2020. PMID: 32276636.

168. Ouattara A, Niangaly A, Adams M, Coulibaly D, Kone AK, Traore K, Laurens MB, Tolo Y, Kouriba B, Diallo DA, Doumbo OK, Plowe CV, Djimdé A, Thera MA, Laufer MK, Takala-Harrison S, Silva JC. Epitope-based sieve analysis of Plasmodium falciparum sequences from a FMP2.1/AS02A vaccine trial is consistent with differential vaccine efficacy against immunologically relevant AMA1 variants. Vaccine 38:5700, 2020. PMID: 32571720.

169. Bradwell KR, Coulibaly D, Koné AK, Laurens MB, Dembélé A, Tolo Y, Traoré K, Niangaly A, Berry AA, Kouriba B, Plowe CV, Doumbo OK, Lyke KE, Takala-Harrison S, Thera MA, Travassos MA, Serre D. Host and parasite transcriptomic changes upon successive Plasmodium falciparum infections in early childhood. mSystems 5:e00116, 2020. PMID: 32636334.

170. Huang F, Shrestha B, Liu H, Tang LH, Zhou SS, Zhou XN, Takala-Harrison S, Ringwald P, Nyunt MM, Plowe CV. No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China-Myanmar border. Malaria Journal 19:334, 2020. PMID: 32928233.

171. Friedman-Klabanoff DJ, Travassos MA, Ifeonu OO, Agrawal S, Ouattara A, Pike A, Bailey JA, Adams M, Coulibaly D, Lyke KE, Laurens MB, Takala-Harrison S, Kouriba B, Kone AK, Doumbo OK, Patel JJ, Thera MA, Felgner PL, Tan JC, Plowe CV, Berry AA. Epitope-specific antibody responses to a Plasmodium falciparum subunit vaccine target in a malaria-endemic population. Journal of Infectious Diseases 223:1943-1947, 2021. PMID: 32992328.

172. Bogale HN, Cannon MV, Keita K, Camara D, Barry Y, Keita M, Coulibaly D, Kone AK, Doumbo OK, Thera MA, Plowe CV, Travassos M, Irish S, Serre D. Relative contributions of various endogenous and exogenous factors to the mosquito microbiota. Parasites and Vectors 13:619, 2020. PMID: 33303025.

173. Hoffman-Hall A, Puett R, Silva JA, Chen D, Baer A, Han KT, Han ZY, Thi A, Htay T, Thein ZW, Aung PP, Plowe CV, Nyunt MM, Loboda TV. Malaria exposure in Ann Township, Myanmar, as a function of land cover and land use: Combining satellite earth observations and field surveys. Geohealth 4:e2020GH000299, 2020. PMID: 33364532.

174. Huang F, Jacob CG, Takala-Harrison S, Adams M, Yang HL, Liu H, Xia ZG, Zhou SS, Tang LH, Plowe CV. Genomic epidemiology of antimalarial drug resistance in Plasmodium falciparum in Southern China. Frontiers in Cellular and Infection Microbiology 10:610985, 2021. PMID: 33489939.

175. Markwalter CF, Ngasala B, Mowatt T, Basham C, Park Z, Loya M, Muller M, Plowe C, Nyunt M, Lin JT. Direct comparison of standard and ultrasensitive PCR for the detection of Plasmodium falciparum from dried blood spots in Bagamoyo, Tanzania. American Journal of Tropical Medicine & Hygiene 104:1371-1374, 2021. PMID: 33556035.

176. MalariaGEN, Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, Amato R, Amenga-Etego L, Andagalu B, Anderson TJC, Andrianaranjaka V, Apinjoh T, Ariani C, Ashley EA, Auburn S, Awandare G, Ba H, Baraka V, Barry AE, Bejon P, Bertin GI, Boni MF, Borrmann S, Bousema T, Branch O, Bull PC, Busby GBJ, Chookajorn T, Chotivanich K, Claessens A, Conway D, Craig A, D'Alessandro U, Dama S, Day NP, Denis B, Diakite M, Djimdé A, Dolecek C, Dondorp AM, Drakeley C, Drury E, Duffy P, Echeverry DF, Egwang TG, Erko B, Fairhurst RM, Faiz A, Fanello CA, Fukuda MM, Gamboa D, Ghansah A, Golassa L, Goncalves S, Hamilton WL, Harrison GLA, Hart L, Henrichs C, Hien TT, Hill CA, Hodgson A, Hubbart C, Imwong M, Ishengoma DS, Jackson SA, Jacob CG, Jeffery B, Jeffreys AE, Johnson KJ, Jyothi D, Kamaliddin C, Kamau E, Kekre M, Kluczynski K, Kochakarn T, Konaté A, Kwiatkowski DP, Kyaw MP, Lim P, Lon C, Loua KM, Maïga-Ascofaré O, Malangone C, Manske M, Marfurt J, Marsh K, Mayxay M, Miles A, Miotto O, Mobegi V, Mokuolu OA, Montgomery J, Mueller I, Newton PN, Nguyen T, Nguyen TN, Noedl H, Nosten F, Noviyanti R, Nzila A, Ochola-Oyier LI, Ocholla H, Oduro A, Omedo I, Onyamboko MA, Ouedraogo JB, Oyebola K, Pearson RD, Peshu N, Phyo AP, Plowe CV, Price RN, Pukrittayakamee S, Randrianarivelojosia M, Rayner JC, Ringwald P, Rockett KA, Rowlands K, Ruiz L, Saunders D, Shayo A, Siba P, Simpson VJ, Stalker J, Su XZ, Sutherland C, Takala-Harrison S, Tavul L, Thathy V, Tshefu A, Verra F, Vinetz J, Wellems TE, Wendler J, White NJ, Wright I, Yavo W, Ye H. An open dataset of Plasmodium falciparum genome variation in 7,000 worldwide samples. Wellcome Open Research 6:42, 2021. PMID: 33824913.

177. Laurens MB, Mungwira RG, Nampota N, Nyirenda OM, Divala TH, Kanjala M, Mkandawire FA, Galileya LT, Nyangulu W, Mwinjiwa E, Downs M, Tillman A, Taylor TE, Mallewa J, Plowe CV, van Oosterhout JJ, Laufer MK. Revisiting co-trimoxazole prophylaxis for African adults in the era of antiretroviral therapy: A randomized controlled clinical trial. Clinical Infectious Diseases 21:ciab252, 2021. PMID: 33744963.

178. Ventimiglia NT, Stucke EM, Coulibaly D, Berry AA, Lyke KE, Laurens MB, Bailey JA, Adams M, Niangaly A, Kone AK, Takala-Harrison S, Kouriba B, Doumbo OK, Felgner PL, Plowe CV, Thera MA, Travassos MA. Malian adults maintain serologic responses to virulent PfEMP1s amid seasonal patterns of fluctuation. Scientific Reports 11:14401, 2021. PMID: 34257318.

179. Maiga H, Grivoyannis A, Sagara I, Traore K, Traore OB, Tolo Y, Traore A, Bamadio A, Traore ZI, Sanogo K, Doumbo OK, Plowe CV, Djimde AA. Selection of pfcrt K76 and pfmdr1 N86 coding alleles after uncomplicated malaria treatment by artemether-lumefantrine in Mali. International Journal of Molecular Sciences 22:6057, 2021. PMID: 34205228.

180. Cannon MV, Bogale HN, Bhalerao D, Keita K, Camara D, Barry Y, Keita M, Coulibaly D, Kone AK, Doumbo OK, Thera MA, Plowe CV, Travassos MA, Irish SR, Yeroshefsky J, Dorothy J, Prendergast B, St Laurent B, Fritz ML, Serre D. High- throughput detection of eukaryotic parasites and arboviruses in mosquitoes. Biology Open 10:bio058855, 2021. PMID: 34156069.

181. Edwards HM, Dixon R, Zegers de Beyl C, Celhay O, Rahman M, Myint Oo M, Lwin T, Lin Z, San T, Thwe Han K, Myaing Nyunt M, Plowe C, Stresman G, Hall T, Drakeley C, Hamade P, Aryal S, Roca-Feltrer A, Hlaing T, Thi A. Prevalence and seroprevalence of Plasmodium infection in Myanmar reveals highly heterogeneous transmission and a large hidden reservoir of infection. PLoS One 16:e0252957, 2021. PMID: 34106995.

182. Berry AA, Obiero JM, Travassos MA, Ouattara A, Coulibaly D, Adams M, de Assis RR, Jain A, Taghavian O, Sy A, Nakajima R, Jasinskas A, Laurens MB, Takala-Harrison S, Kouriba B, Kone AK, Doumbo OK, Sim BKL, Hoffman SL, Plowe CV, Thera MA, Felgner PL, Lyke KE. Immunoprofiles associated with controlled human malaria infection and naturally acquired immunity identify a shared IgA pre-erythrocytic immunoproteome. NPJ Vaccines 6:115, 2021. PMID: 34518543.

183. Stucke EM, Dara A, Dwivedi A, Hodges TK, Ott S, Coulibaly D, Koné AK, Traoré K, Guindo B, Tangara BM, Niangaly A, Daou M, Diarra I, Tolo Y, Sissoko M, Tallon LJ, Sadzewicz L, Zhou AE, Laurens MB, Ouattara A, Kouriba B, Doumbo OK, Takala-Harrison S, Serre D, Plowe CV, Thera MA, Travassos MA, Silva JC. Successful profiling of Plasmodium falciparum var gene expression in clinical samples via a custom capture array. mSystems. 6:e0022621, 2021. PMID: 34846163

184. Markwalter CF, Nyunt MH, Han ZY, Henao R, Jain A, Taghavian O, Felgner PL, Han KT, Nyunt MM, Plowe CV. Antibody signatures of asymptomatic Plasmodium falciparum malaria infections measured from dried blood spots. Malar Journal, 20:378, 2021. PMID: 34556121

185. Ouattara A, Dwivedi A, Adams M, Niangaly A, Laurens MB, Nyunt MM, Plowe CV, Djimde A, Takala-Harrison S, Silva JC. An in silico analysis of malaria pre- erythrocytic-stage antigens interpreting worldwide genetic data to suggest vaccine candidate variants and epitopes. Microorganisms 10:1090, 2022. PMID: 35744609.

186. Mungwira RG, Laurens MB, Nyangulu W, Divala TH, Nampota-Nkomba N, Buchwald AG, Nyirenda OM, Mwinjiwa E, Kanjala M, Galileya LT, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa J, van Oosterhout JJ, Laufer MK; TSCQ Study Team. High burden of malaria among Malawian adults on antiretroviral therapy after discontinuing prophylaxis. AIDS 36:1675-1682, 2022. PMID: 35848575.

187. Li Y, Stewart K, Han KT, Han ZY, Aung PP, Thein ZW, Htay T, Chen D, Nyunt MM, Plowe CV. Understanding spatio-temporal human mobility patterns for malaria control using a multi-agent mobility simulation model. Clinical Infectious Diseases 19:ciac568, 2022. PMID: 35851600.

188. Egger JR, Han KT, Fang H, Zhou XN, Hlaing TM, Thant M, Han ZY, Wang XX, Hong T, Platt A, Simmons R, Thane TK, Meng M, Hogue J, Markwalter CF, Thi A, Htay T, Thein ZW, Paing AK, Tun ZM, Oo SM, Aung PP, Nyunt MM, Plowe CV. Temporal dynamics of subclinical malaria in different transmission zones of Myanmar. American Journal of Tropical Medicine & Hygiene Epub ahead of print, 2022. PMID: 35895341.

189. Sobota RS, Goron AR, Berry AA, Bailey JA, Coulibaly D, Adams M, Kone AK, Kouriba B, Doumbo OK, Sztein MB, Felgner PL, Plowe CV, Lyke KE, Thera MA, Travassos MA. Serologic and cytokine profiles of children with concurrent cerebral malaria and severe malarial anemia are distinct from other subtypes of severe malaria. American Journal of Tropical Medicine & Hygiene Epub ahead of print, 2022. PMID: 35895583.

190. Coulibaly D, Kone AK, Traore K, Niangaly A, Kouriba B, Arama C, Zeguime A, Dolo A, Lyke KE, Plowe CV, Abebe Y, Potter GE, Kennedy JK, Galbiati SM, Nomicos E, Deye GA, Richie TL, James ER, Kc N, Sim BKL, Hoffman SL, Doumbo OK, Thera MA, Laurens MB; DMID 15-0052 PfSPZ-CVac Study Team. PfSPZ-CVac malaria vaccine demonstrates safety among malaria-experienced adults: A randomized, controlled phase 1 trial. EClinicalMedicine 52:101579, 2022. PMID: 35928033.

191. Sirima SB, Ouédraogo A, Tiono AB, Kaboré JM, Bougouma EC, Ouattara MS, Kargougou D, Diarra A, Henry N, Ouédraogo IN, Billingsley PF, Manoj A, Abebe Y, Kc N, Ruben A, Richie TL, James ER, Joshi S, Shrestha B, Strauss K, Lyke KE, Plowe CV, Potter GE, Cox C, Jones W, Sim BKL, Hoffman SL, Laurens MB. A randomized controlled trial showing safety and efficacy of a whole sporozoite vaccine against endemic malaria. Science Translational Medicine 14:eabj3776, 2022. PMID: 36475905.

192. Tebben K, Yirampo S, Coulibaly D, Koné AK, Laurens MB, Stucke EM, Dembélé A, Tolo Y, Traoré K, Niangaly A, Berry AA, Kouriba B, Plowe CV, Doumbo OK, Lyke KE, Takala-Harrison S, Thera MA, Travassos MA, Serre D. Malian children infected with Plasmodium ovale and Plasmodium falciparum display very similar gene expression profiles. PLoS Neglected Tropical Diseases 17:e0010802, 2023. PMID: 36696438.

193. Nyangulu W, Mungwira RG, Divala TH, Nampota-Nkomba N, Nyirenda OM, Buchwald AG, Miller J, Earland DE, Adams M, Plowe CV, Taylor TE, Mallewa JE, van Oosterhout JJ, Parikh S, Laurens MB, Laufer MK; TSCQ Study Team. Artemether- lumefantrine efficacy among adults on antiretroviral therapy in Malawi. Malar Journal 22:32, 2023. PMID: 36707795.

194. MalariaGEN; Abdel Hamid MM, Abdelraheem MH, Acheampong DO, Ahouidi A, Ali M, Almagro-Garcia J, Amambua-Ngwa A, Amaratunga C, Amenga-Etego L, Andagalu B, Anderson T, Andrianaranjaka V, Aniebo I, Aninagyei E, Ansah F, Ansah PO, Apinjoh T, Arnaldo P, Ashley E, Auburn S, Awandare GA, Ba H, Baraka V, Barry A, Bejon P, Bertin GI, Boni MF, Borrmann S, Bousema T, Bouyou-Akotet M, Branch O, Bull PC, Cheah H, Chindavongsa K, Chookajorn T, Chotivanich K, Claessens A, Conway DJ, Corredor V, Courtier E, Craig A, D'Alessandro U, Dama S, Day N, Denis B, Dhorda M, Diakite M, Djimde A, Dolecek C, Dondorp A, Doumbia S, Drakeley C, Drury E, Duffy P, Echeverry DF, Egwang TG, Enosse SMM, Erko B, Fairhurst RM, Faiz A, Fanello CA, Fleharty M, Forbes M, Fukuda M, Gamboa D, Ghansah A, Golassa L, Goncalves S, Harrison GLA, Healy SA, Hendry JA, Hernandez-Koutoucheva A, Hien TT, Hill CA, Hombhanje F, Hott A, Htut Y, Hussein M, Imwong M, Ishengoma D, Jackson SA, Jacob CG, Jeans J, Johnson KJ, Kamaliddin C, Kamau E, Keatley J, Kochakarn T, Konate DS, Konaté A, Kone A, Kwiatkowski DP, Kyaw MP, Kyle D, Lawniczak M, Lee SK, Lemnge M, Lim P, Lon C, Loua KM, Mandara CI, Marfurt J, Marsh K, Maude RJ, Mayxay M, Maïga-Ascofaré O, Miotto O, Mita T, Mobegi V, Mohamed AO, Mokuolu OA, Montgomery J, Morang'a CM, Mueller I, Murie K, Newton PN, Ngo Duc T, Nguyen T, Nguyen TN, Nguyen Thi Kim T, Nguyen Van H, Noedl H, Nosten F, Noviyanti R, Ntui VN, Nzila A, Ochola-Oyier LI, Ocholla H, Oduro A, Omedo I, Onyamboko MA, Ouedraogo JB, Oyebola K, Oyibo WA, Pearson R, Peshu N, Phyo AP, Plowe CV, Price RN, Pukrittayakamee S, Quang HH, Randrianarivelojosia M, Rayner JC, Ringwald P, Rosanas-Urgell A, Rovira-Vallbona E, Ruano-Rubio V, Ruiz L, Saunders D, Shayo A, Siba P, Simpson VJ, Sissoko MS, Smith C, Su XZ, Sutherland C, Takala-Harrison S, Talman A, Tavul L, Thanh NV, Thathy V, Thu AM, Toure M, Tshefu A, Verra F, Vinetz J, Wellems TE, Wendler J, White NJ, Whitton G, Yavo W, van der Pluijm RW. Pf7: an open dataset of Plasmodium falciparum genome variation in 20,000 worldwide samples. Wellcome Open Research 8:22, 2023. PMID: 36864926.

195. Mbambo G, Dwivedi A, Ifeonu OO, Munro JB, Shrestha B, Bromley RE, Hodges T, Adkins RS, Kouriba B, Diarra I, Niangaly A, Kone AK, Coulibaly D, Traore K, Dolo A, Thera MA, Laurens MB, Doumbo OK, BU, Berry AA, Travassos M, Lyke KE, Silva JC. Immunogenomic profile at baseline predicts host susceptibility to clinical malaria. Frontiers in Immunology 14:1179314, 2023. PMID: 37465667

196. Hoffman-Hall A, Puett R, Silva JA, Chen D, Bredder A, Shevade V, Han ZY, Han KT, Aung PP, Plowe CV, Nyunt MM, Loboda TV. Comparison of deforestation and forest land use factors for malaria elimination in Myanmar. IJID Regions 8:75, 2023.

197. Tewey MA, Coulibaly D, Lawton JG, Stucke EM, Zhou AE, Berry AA, Bailey JA, Pike A, Dara A, Ouattara A, Lyke KE, Ifeonu O, Laurens MB, Adams M, Takala- Harrison S, Niangaly A, Kouriba B, Koné AK, Rowe JA, Doumbo OK, Patel JJ, Tan JC, Felgner PL, Plowe CV, Thera MA, Travassos MA. Natural immunity to malaria preferentially targets the endothelial protein C receptor-binding regions of PfEMP1s. mSphere 8:e0045123, 2023. PMID: 37791774.

198. Tebben K, Yirampo S, Coulibaly D, Koné AK, Laurens MB, Stucke EM, Dembélé A, Tolo Y, Traoré K, Niangaly A, Berry AA, Kouriba B, Plowe CV, Doumbo OK, Lyke KE, Takala-Harrison S, Thera MA, Travassos MA, Serre D. Gene expression analyses reveal differences in children's response to malaria according to their age. Nature Communications 15:2021, 2024. PMID: 38448421.

Honors & Awards (Selected):

2024 Fiction manuscript Pflug Figures It Out selected as “Top Pick” for Claymore Award, Killer Nashville International Writers’ Conference

2019 Elected to Association of American Physicians, National Honor Society of Physician-Scientists

2015 Elected to American Clinical and Climatological Association

2014-2015 President, American Society of Tropical Medicine & Hygiene

2013 Fellow, American Society of Tropical Medicine & Hygiene (FASTMH)

2013 Award for Outstanding Work in Science as Related to Medicine, American College of Physicians

2007 Howard Hughes Medical Institute Investigator in Patient-Oriented Research, Howard Hughes Medical Institute

2007 Doris Duke Distinguished Clinical Scientist Award, Doris Duke Charitable Foundation

2005 Elected to American Society for Clinical Investigation, National Honor Society of Physician-Scientists

2002 Bailey K. Ashford Medal, American Society of Tropical Medicine & Hygiene, awarded for distinguished work in tropical medicine